Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

C3_BILIARY_GALLBLADDER_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C22, C23&, C24 Hospital discharge: ICD-9 — 155\|156 Hospital discharge: ICD-8 — 155\|156 Cause of death: ICD-10 — C22, C23&, C24 Cause of death: ICD-9 — 155\|156 Cause of death: ICD-8 — 155\|156 Cancer registry: Topography ICD-O-3 — C2[2-4] Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	3121
4. Check minimum number of events None	3121
5. Include endpoints C3_LIVER_INTRAHEPATIC_BILE_DUCTS_WIDE C3_GALLBLADDER_WIDE C3_BILIARY_TRACT_WIDE	3121
6. Filter based on genotype QC (FinnGen only)	2768

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_BILIARY_GALLBLADDER_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_LIVER_INTRAHEPATIC_BILE_DUCTS_WIDE\|C3_GALLBLADDER_WIDE\|C3_BILIARY_TRACT_WIDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C2[2-4]
HD_ICD_9	155\|156
HD_ICD_8	155\|156
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C2[2-4]
COD_ICD_9	155\|156
COD_ICD_8	155\|156
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C2[2-4]
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2768	931	1837
Unadjusted period prevalence (%)	0.67	0.33	0.84
Median age at first event (years)	72.09	71.33	72.47

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2872: Matched controls
28719

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

19.1

323.3

260

149

WF002

NOMESCO Finland

Radical radiotherapy

89.7

321.9

169

JN3AD

NOMESCO Finland

Abdominal CT examination

5.4

317.1

773

1832

K83.0

ICD-10 Finland

Cholangitis

19.0

307.7

282

164

L01BC06

ATC

capecitabine; oral

+∞

307.7

394

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

324

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

307.7

1160

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

9.9

307.7

825

1121

JN4AD

NOMESCO Finland

Body CT examination

12.1

307.7

832

933

N02AA05

ATC

oxycodone; systemic

8.2

307.7

1366

2864

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

307.7

339

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

307.7

601

R18

ICD-10 Finland

Ascites

18.4

307.7

290

174

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

106.0

307.7

179

A04AA01

ATC

ondansetron; systemic, rectal

19.9

307.7

452

267

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

11.7

307.7

380

368

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

162.6

307.7

825

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

30.5

307.7

333

123

A03FA01

ATC

metoclopramide; systemic, rectal

13.6

307.7

1286

1612

H02AB02

ATC

dexamethasone; systemic

58.5

307.7

643

141

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

6446.5

307.7

539

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

307.7

422

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

24.0

307.7

289

133

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

307.7

677

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

21.3

307.7

345

183

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

99.9

307.7

715

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

20.4

307.7

298

162

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

68.9

307.7

330

K83.1

ICD-10 Finland

Obstruction of bile duct

63.2

307.7

408

A04AA02

ATC

granisetron; systemic, transdermal

988.8

307.7

493

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

1348

WX302

NOMESCO Finland

Thoracal epidural anesthesy

21.1

307.7

422

233

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

18.7

307.7

274

161

JN4CD

NOMESCO Finland

Very extensive body CT

29.4

307.7

384

150

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

19.6

307.7

357

206

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2253.9

307.7

412

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

30.0

307.7

356

135

JN4BD

NOMESCO Finland

Extensive body CT

10.0

307.7

535

645

UJK02

NOMESCO Finland

ERCP

16.8

307.7

474

333

Z51.5

ICD-10 Finland

Palliative care

25.4

307.7

1168

756

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

26.6

307.7

235

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

27.0

307.7

268

109

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

15.4

300.4

270

192

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

776.2

290.0

281

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

5.0

287.9

758

1905

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

7.1

276.8

463

762

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

14.4

276.2

258

196

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

+∞

266.9

252

WZC00

NOMESCO Finland

Treatment plan or consultation

3.9

265.9

1248

4773

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

13.7

254.0

244

194

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

22.0

251.4

188

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

+∞

246.5

233

198

Kela drug reimbursment

Sorafenib

+∞

244.3

231

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

+∞

228.2

216

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

220.7

209

C61

ICD-10 Finland

Malignant neoplasm of prostate

334.5

214.7

215

Z94.4

ICD-10 Finland

Liver transplant status

71.1

213.7

116

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

7.0

212.4

346

549

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

77.7

209.1

112

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

87.1

206.7

109

JLC30

NOMESCO Finland

Pancreatoduodenectomy

1050.0

202.6

196

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

9.0

200.5

259

314

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

23.3

197.7

144

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

36.7

197.0

123

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

191.8

182

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

36.1

188.3

118

XX3DW

NOMESCO Finland

Time consuming IT work

6.3

180.0

326

574

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.6

179.8

493

1249

JJC00

NOMESCO Finland

Allogenic transplantation of liver

81.8

178.6

WW500

NOMESCO Finland

Blood transfusion

9.7

173.2

208

229

WZC30

NOMESCO Finland

Teaching

3.8

170.4

627

1964

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

50.7

169.8

WF049

NOMESCO Finland

Radiotherapy of metastasis

873.4

169.7

165

A06AH03

ATC

naloxegol; oral

24.5

168.5

120

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

158.8

151

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

21.3

150.1

113

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

1540.4

149.3

144

A05AA02

ATC

ursodeoxycholic acid; oral

14.4

148.3

136

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

+∞

148.2

141

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

+∞

146.1

139

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.5

143.3

609

2078

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1462.7

142.9

138

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

39.3

137.2

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

37.6

135.6

B01AB10

ATC

tinzaparin; parenteral

4.1

133.6

411

1124

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

24.3

131.7

L01XE05

ATC

[U] sorafenib

+∞

131.3

125

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

22.5

130.6

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

1316.3

130.2

126

323

Kela drug reimbursment

Sorafenib

+∞

130.2

124

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

129.4

1152

5848

L02AE02

ATC

leuprorelin; implant, parenteral

61.5

129.4

A04AA55

ATC

palonosetron, combinations; systemic

+∞

128.1

122

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

+∞

128.1

122

D77

ICPC

Malignant digestive neopl other/NOS

651.3

127.4

125

C24.09

ICD-10 Finland

Biliary duct or passage NOS

+∞

126.0

120

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

+∞

123.8

118

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1239.9

122.9

119

8160/3-C24.9

ICD-O-3

Cholangiocarcinoma of billiary tract, NOS

+∞

120.7

115

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

119.4

843

3791

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

33.9

119.2

116

Kela drug reimbursment

Prostate cancer

+∞

118.6

113

127

Kela drug reimbursment

Transplant complication

13.1

118.3

114

WX402

NOMESCO Finland

General anaesthesia

3.0

117.3

664

2654

JAH01

NOMESCO Finland

Laparoscopy

6.9

117.1

186

284

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

+∞

116.4

111

R50.9

ICD-10 Finland

Fever, unspecified

3.0

113.5

606

2341

R4190

NOMESCO Finland

Nutritional therapy

7.2

112.5

171

249

TPH07

NOMESCO Finland

Cathetrisation of artery

3.2

110.3

501

1760

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

53.7

110.3

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

110.1

105

C24.02

ICD-10 Finland

Common bile duct

+∞

108.0

103

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

12.1

107.8

109

C24.00

ICD-10 Finland

Hepatic duct

+∞

106.9

102

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

105.9

101

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

34.3

105.4

UJK12

NOMESCO Finland

Peroral cholangioscopy

45.2

104.7

A07AA11

ATC

rifaximin; oral

31.6

104.5

C03DA01

ATC

spironolactone; oral

2.8

103.7

668

2841

A79

ICPC

Malignancy NOS

185.1

103.1

107

B01AB05

ATC

enoxaparin; parenteral

2.4

102.1

1022

5357

I81

ICD-10 Finland

Portal vein thrombosis

23.0

101.6

8000/3-C24.9

ICD-O-3

Neoplasm, malignant of billiary tract, NOS

+∞

100.6

A06AD11

ATC

lactulose; oral

2.6

100.5

738

3346

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

18.9

99.7

K76.9

ICD-10 Finland

Liver disease, unspecified

9.8

98.8

116

123

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

97.4

L03AA02

ATC

filgrastim; parenteral

119.9

96.6

104

N02AX02

ATC

tramadol; systemic, rectal

2.2

94.6

1415

8711

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

20.8

93.5

C24.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of biliary tract

+∞

93.2

L03AA13

ATC

pegfilgrastim; parenteral

472.7

92.8

J01MA12

ATC

levofloxacin; systemic

2.5

92.7

721

3345

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

927.5

92.4

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

92.2

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

52.9

90.7

ZX120

NOMESCO Finland

Intravenous

3.6

90.1

326

987

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

90.1

JJA20

NOMESCO Finland

Open biopsy of liver

51.9

88.6

8140/3-C24.1

ICD-O-3

Adenocarcinoma, NOS, of ampulla of Vater

+∞

88.0

3019

Kela drug reimbursment

Lenvatinib

+∞

88.0

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.7

87.5

141

218

L01EX02

ATC

sorafenib; oral

+∞

86.9

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

15.7

86.4

L01EX08

ATC

lenvatinib; oral

+∞

85.9

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

85.9

1508

Kela drug reimbursment

Lenvatinib

+∞

85.9

JAH00

NOMESCO Finland

Laparotomy

6.0

85.5

155

270

L04AD02

ATC

tacrolimus; systemic

13.5

84.6

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

5.6

83.7

165

311

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

424.7

83.4

WPB10

NOMESCO Finland

Making a convalescent care decision

35.3

82.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

79.8

1570

10504

JKA20

NOMESCO Finland

Cholecystectomy

5.0

78.4

177

376

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.2

77.6

217

547

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

14.4

76.0

L02BG04

ATC

letrozole; oral

36.7

75.3

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

74.9

725

3667

115

Kela drug reimbursment

Breast cancer

+∞

74.3

D70.82

ICD-10 Finland

Drug-induced neutropenia

21.5

73.6

D97

ICPC

Liver disease NOS

16.8

72.9

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

30.5

72.8

K75.0

ICD-10 Finland

Abscess of liver

24.1

72.7

L04AA06

ATC

mycophenolic acid; systemic

7.3

71.3

106

150

A02BC02

ATC

pantoprazole; systemic

2.1

70.9

2004

15020

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

32.6

69.7

B18.2

ICD-10 Finland

Chronic viral hepatitis C

12.9

69.3

XX2RW, ,

NOMESCO Finland

13.5

69.1

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

181.9

68.4

PJA12

NOMESCO Finland

Sentinel node biopsy

684.2

68.3

WF004

NOMESCO Finland

Palliative radiotherapy

684.2

68.3

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

124.8

68.2

8160/3-C24.0

ICD-O-3

Cholangiocarcinoma of extrahepatic bile duct

+∞

68.0

C22.7

ICD-10 Finland

Malignant neoplasm: Other specified carcinomas of liver

+∞

68.0

D13.4

ICD-10 Finland

Benign neoplasm: Liver

18.3

67.3

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

28.6

66.8

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.0

66.5

195

508

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

121.3

66.1

B01AB04

ATC

dalteparin; parenteral

3.8

65.1

211

590

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

102.5

64.1

JJB30

NOMESCO Finland

Excision of two segments of liver

642.2

64.1

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

63.8

HAB40

NOMESCO Finland

Wedge excision of mammary gland

20.3

62.7

8000/3-C22.1

ICD-O-3

Neoplasm, malignant of intrahepatic bile duct

+∞

61.7

A04AD12

ATC

aprepitant; systemic

+∞

61.7

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

11.2

61.6

R4110

NOMESCO Finland

Physiotherapy

2.0

60.5

833

4777

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

10.2

59.4

N02AA01

ATC

morphine; systemic, rectal

5.9

58.6

106

184

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

58.2

1085

6892

C03CA01

ATC

furosemide; systemic

1.9

58.0

1313

8877

PC2SC

NOMESCO Finland

Liver angiography with X-ray

579.5

57.9

8140/3-C24.0

ICD-O-3

Adenocarcinoma, NOS, of extrahepatic bile duct

+∞

57.5

A10AE04

ATC

insulin glargine; parenteral

2.5

57.4

428

1910

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

569.1

56.8

A10AB05

ATC

insulin aspart; parenteral

2.7

56.4

337

1351

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

13.2

54.6

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

54.3

UJF32

NOMESCO Finland

Coloscopy

2.0

54.0

819

4829

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

6.6

53.7

135

176

Kela drug reimbursment

Regorafenib

+∞

52.2

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

52.2

WX004

NOMESCO Finland

Patient-controlled sedation

15.1

52.0

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.8

51.9

163

445

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

9.3

51.4

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.2

51.1

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

50.9

535

2751

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

50.9

433

2042

NK6AN

NOMESCO Finland

Total body bone isotope imaging

21.4

50.6

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

50.1

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

176.5

50.0

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.6

49.7

121

273

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

49.1

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

5.3

48.9

191

J01MA02

ATC

ciprofloxacin; systemic

1.8

47.7

1207

8296

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

47.3

974

6289

K92.0

ICD-10 Finland

Haematemesis

3.9

47.1

143

381

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.0

47.0

102

209

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

238.8

46.1

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

454.8

45.4

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

45.4

865

5442

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

12.3

45.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

45.0

633

3605

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

44.9

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

99.7

44.9

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

228.5

44.0

8000/3-C24.0

ICD-O-3

Neoplasm, malignant of extrahepatic bile duct

+∞

43.9

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

43.9

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

8.2

43.6

WF003

NOMESCO Finland

Adjuvant radiotherapy

152.3

42.9

TJA10

NOMESCO Finland

Laparocentesis

95.6

42.9

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

42.8

C22

ICD-10 Finland

Malignant neoplasm of liver and intrahepatic bile ducts

+∞

42.8

A10BA02

ATC

metformin; oral

1.8

42.5

1058

7174

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

42.0

456

2361

L02BB03

ATC

bicalutamide; oral

+∞

41.8

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

41.8

8140/3-C24.9

ICD-O-3

Adenocarcinoma, NOS, of billiary tract, NOS

+∞

41.8

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

413.4

41.2

WVA20

NOMESCO Finland

Medicine administration

4.2

40.7

110

269

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

+∞

40.7

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

40.7

369

Kela drug reimbursment

Regorafenib

+∞

40.7

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

403.1

40.2

WPA44, ,

SPAT

15.4

40.0

WPA13

NOMESCO Finland

Palliative consultation

14.6

39.9

8140/3-C80.9

ICD-O-3

Adenocarcinoma, NOS, of unknown primary site

+∞

39.7

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

39.4

927

6155

L04AD01

ATC

ciclosporin; systemic

5.7

38.8

128

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

38.6

Y77

ICPC

Malignant neoplasm prostate

85.3

37.9

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.9

37.8

WW200, ,

SPAT

0.5

36.9

323

6142

SPAT1262

SPAT

Handing over of treatment supplies

1.9

36.7

595

3525

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

4.6

36.3

194

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

60.8

36.2

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

361.8

36.0

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

35.5

T90

ICPC

Diabetes non-insulin dependent

1.7

35.5

855

5684

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

35.4

497

2805

ZX090

NOMESCO Finland

Other technic of radiotherapy

59.4

35.2

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

351.4

35.0

JJB71

NOMESCO Finland

Laparoscopic resection of liver

351.4

35.0

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

3.3

34.7

131

404

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

34.4

8000/3-C23.9

ICD-O-3

Neoplasm, malignant of gallbladder

+∞

34.4

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

341.1

34.0

A41.8

ICD-10 Finland

Other specified sepsis

3.9

33.8

101

266

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

4.3

33.8

205

K85.8

ICD-10 Finland

Other acute pancreatitis

7.9

33.6

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

12.9

33.2

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

172.0

32.8

ZX070

NOMESCO Finland

Intensity modified radiotherapy

118.1

32.7

WX002

NOMESCO Finland

Sedation and analgesia

1.8

32.6

558

3348

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

+∞

32.3

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

32.3

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

32.3

L01EX05

ATC

regorafenib; oral

+∞

32.3

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

32.3

JFB30

NOMESCO Finland

Right hemicolectomy

8.7

32.3

SPAT1109

SPAT

Analgesia with portable analgesic pump

10.7

32.2

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

320.5

31.9

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

73.0

31.9

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

166.9

31.7

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.4

31.5

117

357

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

31.3

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

30.8

249

4924

HAC20

NOMESCO Finland

Total mastectomy

86.1

30.8

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.6

30.6

162

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

30.3

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

30.3

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.2

30.2

121

C10AA07

ATC

rosuvastatin; oral

0.5

30.2

443

7219

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

305.5

29.8

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.4

29.8

178

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

29.2

A10BH01

ATC

sitagliptin; oral

2.0

29.0

362

1955

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

294.9

28.8

ZXC40

NOMESCO Finland

Use of ultrasound

11.2

28.5

A10BB12

ATC

glimepiride; oral

2.0

28.2

327

1720

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

28.2

JJA44

NOMESCO Finland

Laparoscopic destruction of lesion of liver

+∞

28.2

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

28.2

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

284.2

27.8

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

284.2

27.8

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.3

27.5

105

326

ZXE00

NOMESCO Finland

One hour or less

1.6

27.4

949

6824

ZX050

NOMESCO Finland

Stereotactic radiotherapy

53.9

27.2

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

27.1

JKC30

NOMESCO Finland

Partial excision of bile duct and anastomosis to jejunum

+∞

27.1

C24.01

ICD-10 Finland

Cystic duct

+∞

27.1

D76

ICPC

Malignant neoplasm pancreas

97.7

26.7

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

26.4

368

2059

JN6AD

NOMESCO Finland

CT of torso and neck

7.4

26.3

K72.1

ICD-10 Finland

Chronic hepatic failure

23.4

26.1

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

26.1

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

26.1

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

26.1

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

7.7

25.9

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.2

25.5

165

ZZR00

NOMESCO Finland

Flap of skin

7.3

25.4

SPAT1255

SPAT

Intravenous administration of medicine

2.2

25.4

226

1074

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.8

25.2

130

480

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.5

25.1

254

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

25.0

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

25.0

149

592

WX882

NOMESCO Finland

High dependency care

3.1

24.7

105

348

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

24.7

337

1871

B03XA02

ATC

darbepoetin alfa; parenteral

3.9

24.6

187

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

131.2

24.6

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.2

24.1

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.6

24.0

144

574

9680/3-C22.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of liver

+∞

24.0

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

24.0

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

24.0

8140/3-C26.9

ICD-O-3

Adenocarcinoma, NOS, of gastrointestinal tract, NOS

+∞

24.0

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

24.0

H01CB02

ATC

octreotide; parenteral

68.0

23.8

A10BX07

ATC

[U] liraglutide

4.3

23.7

144

WX892

NOMESCO Finland

Monitored bed care

2.1

23.6

244

1229

XW000

NOMESCO Finland

Bone marrow biopsy

3.1

23.5

321

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

23.5

212

1013

160

Kela drug reimbursment

exenatide

3.5

23.3

242

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

36.6

23.0

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.0

22.9

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

22.9

1552X

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUMHEPATIS, NON DEFINITUM PRIM/SEC]

+∞

22.9

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

22.9

142

576

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

22.9

267

1405

C07AG02

ATC

carvedilol; oral

2.1

22.8

239

1210

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

84.1

22.7

JJ5AT, ,

NOMESCO Finland

84.1

22.7

C10AX09

ATC

ezetimibe; oral

0.5

22.7

185

3693

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.1

22.6

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

6.8

22.5

HA1AA

NOMESCO Finland

X-ray mammography

3.3

22.4

258

N06DX01

ATC

memantine; oral

0.3

22.2

2285

N05CF01

ATC

zopiclone; oral

1.5

22.0

906

6697

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

22.0

521

3389

JJA43

NOMESCO Finland

Destruction of lesion of liver

+∞

21.9

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

21.9

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

21.9

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

21.9

C20

ICD-10 Finland

Malignant neoplasm of rectum

221.6

21.6

C50.99

ICD-10 Finland

Breast, unspecified

221.6

21.6

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

21.3

418

2585

JDE00

NOMESCO Finland

Gastrojejunostomy

50.4

21.1

L02BA01

ATC

tamoxifen; oral

50.4

21.1

K92.1

ICD-10 Finland

Melaena

2.1

21.0

201

982

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

20.9

L01XE21

ATC

[U] regorafenib

+∞

20.9

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

20.9

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

7.7

20.8

ZX108

NOMESCO Finland

Inhalation

7.1

20.8

K72.9

ICD-10 Finland

Hepatic failure, unspecified

5.8

20.6

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

20.5

932

7006

A10AE05

ATC

insulin detemir; parenteral

2.2

20.2

185

889

C10AA05

ATC

atorvastatin; oral

0.7

20.1

824

10782

ZXD05

NOMESCO Finland

Urgent procedure

1.5

20.1

784

5709

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.6

20.1

XX4BW, ,

NOMESCO Finland

27.2

20.0

Z3226

NOMESCO Finland

Physiotherapist

1.7

19.9

453

2909

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

19.8

106

399

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

19.8

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

19.8

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

19.8

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

19.8

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.7

19.8

106

400

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

15.4

19.7

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.7

19.7

170

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

19.7

209

1062

Z2446

NOMESCO Finland

Social worker

2.3

19.6

157

714

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

19.4

113

444

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.4

19.3

134

573

K70.4

ICD-10 Finland

Alcoholic hepatic failure

6.5

19.2

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

19.1

380

2353

C10AC01

ATC

colestyramine; oral

3.1

19.1

274

Z3231

NOMESCO Finland

Registered nurse

1.5

19.0

672

4782

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

19.0

299

1732

RS220, ,

NOMESCO Finland

4.8

18.9

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

34.6

18.9

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

5.5

18.8

K70.1

ICD-10 Finland

Alcoholic hepatitis

5.5

18.8

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

3.5

18.8

185

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

18.8

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

18.8

1550A

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary

+∞

18.8

TK800

NOMESCO Finland

Hemodialysis

3.1

18.7

256

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

100.7

18.6

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

191.2

18.5

ZX112

NOMESCO Finland

Subcutaneous

5.7

18.5

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.0

18.5

136

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

17.7

18.2

WPA43, ,

SPAT

25.2

18.2

WPA11

NOMESCO Finland

Developing a plan for palliative care

25.2

18.2

K76.89

ICD-10 Finland

Other specified diseases of liver

21.8

18.2

E0000UV, ,

ATC

1.4

18.1

997

7734

EB4VA, ,

NOMESCO Finland

0.4

17.8

1970

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

20.2

17.7

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

17.7

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

17.7

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

17.7

Z2221

NOMESCO Finland

Medical doctor

1.5

17.7

615

4352

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

95.7

17.6

X76

ICPC

Malignant neoplasm breast female

95.7

17.6

C82.1

ICD-10 Finland

Follicular lymphoma grade II

181.1

17.5

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

181.1

17.5

162

Kela drug reimbursment

liraglutide

3.9

17.3

129

WZC15, ,

NOMESCO Finland

24.2

17.3

EB1VA, ,

NOMESCO Finland

0.5

17.3

131

2706

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.1

17.2

163

793

N02AA03

ATC

hydromorphone; systemic, rectal

25.7

16.9

R11

ICD-10 Finland

Nausea and vomiting

1.9

16.9

216

1171

M04AA01

ATC

allopurinol; systemic

1.6

16.8

462

3098

P20

ICPC

Memory disturbance

0.5

16.8

225

3863

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

14.1

16.8

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

16.7

8140/3-C22.1

ICD-O-3

Adenocarcinoma, NOS, of intrahepatic bile duct

+∞

16.7

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

16.7

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

16.7

L02AE04

ATC

triptorelin; parenteral

+∞

16.7

C22.3

ICD-10 Finland

Malignant neoplasm: Angiosarcoma of liver

+∞

16.7

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

16.7

170

851

ZXC96

NOMESCO Finland

Robot assisted procedure

7.0

16.5

PJD99

NOMESCO Finland

Excision of other lymph nodes

171.0

16.5

Z51.0

ICD-10 Finland

Radiotherapy session

171.0

16.5

A98

ICPC

Health maint/preventive medicine

0.7

16.5

2082

22768

A10AC01

ATC

insulin (human); parenteral

1.8

16.4

268

1568

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

16.4

164

815

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.5

16.4

105

433

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

12.2

16.3

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

16.0

799

6057

K74.3

ICD-10 Finland

Primary biliary cirrhosis

6.0

16.0

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.7

16.0

325

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

15.9

258

1505

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.4

15.9

112

483

WX704

NOMESCO Finland

Intubation

2.0

15.8

184

965

PC1BC

NOMESCO Finland

Extensive angiography of aorta and abdominal arteries

6.4

15.8

G93.4

ICD-10 Finland

Encephalopathy, unspecified

6.9

15.7

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

15.6

272

4356

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

15.6

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

15.6

C22.4

ICD-10 Finland

Malignant neoplasm: Other sarcomas of liver

+∞

15.6

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

15.6

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

15.6

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

15.6

8140/3-C22.0

ICD-O-3

Adenocarcinoma, NOS, of liver

+∞

15.6

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

15.6

P01AB01

ATC

metronidazole; oral, rectal

1.4

15.5

876

6784

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

19.3

15.5

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

22.2

15.5

K51.5

ICD-10 Finland

Left sided colitis

2.9

15.5

252

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

160.8

15.5

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

160.8

15.5

HAB99

NOMESCO Finland

Other partial excision of mammary gland

7.0

15.3

R94.5

ICD-10 Finland

Abnormal results of liver function studies

4.4

15.2

K81.0

ICD-10 Finland

Acute cholecystitis

2.6

15.2

323

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

6.1

15.1

D75

ICPC

Malignant neoplasm colon/rectum

23.5

15.1

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

20.1

15.1

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

14.9

111

490

H02AB06

ATC

prednisolone; systemic

1.4

14.8

1218

10026

D70.89

ICD-10 Finland

Neutropenic splenomegaly

5.5

14.8

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.4

14.8

1845

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

4.5

14.7

J94.8

ICD-10 Finland

Other specified pleural conditions

3.2

14.6

175

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

5.7

14.6

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

14.6

YJ3VG

NOMESCO Finland

MRI examination of abdomen with high intesity magnet for dose design of radiotherapy

+∞

14.6

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

14.6

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

14.6

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

14.6

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

14.6

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

14.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

14.6

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

14.6

R17.0

ICD-10 Finland

Hyperbilirubinaemia with mention of jaundice, not elsewhere classified

80.5

14.6

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

80.5

14.6

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

14.5

828

6412

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

14.4

234

1367

J01DB01

ATC

cefalexin; oral

1.4

14.4

2051

18397

XQ902

NOMESCO Finland

Other photography

4.0

14.3

101

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

4.0

14.3

101

WPA44

NOMESCO Finland

Nursing home for palliative care

19.2

14.2

L04AA10

ATC

[U] sirolimus

42.7

14.1

WPA41

NOMESCO Finland

Psychosocial conversational support in palliative care

42.7

14.1

205

Kela drug reimbursment

Chronic hypertension

1.4

14.0

950

7561

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

6.7

14.0

N05AX08

ATC

risperidone; systemic

0.4

14.0

1981

A10BG03

ATC

pioglitazone; oral

2.4

14.0

391

XF612

NOMESCO Finland

Measurement of central venous pressure

23.9

13.8

PJA10

NOMESCO Finland

Exploration of lymph nodes

6.5

13.6

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

75.5

13.6

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

75.5

13.6

L01XE29

ATC

[U] lenvatinib

+∞

13.5

JJB53

NOMESCO Finland

Excision of segments IV,V, VI, VII and VIII of liver

+∞

13.5

C22.2

ICD-10 Finland

Malignant neoplasm: Hepatoblastoma

+∞

13.5

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

+∞

13.5

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

13.5

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

13.5

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

+∞

13.5

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.6

13.5

124

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

140.6

13.5

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

140.6

13.5

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

13.4

140

707

A10BX04

ATC

[U] exenatide

3.7

13.3

111

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.9

13.2

R10.0

ICD-10 Finland

Acute abdomen

2.4

13.2

358

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

13.2

163

874

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

40.3

13.1

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

13.1

127

624

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

13.0

101

454

A10BH05

ATC

linagliptin; oral

1.8

13.0

183

1022

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

4.1

13.0

K76.7

ICD-10 Finland

Hepatorenal syndrome

11.0

13.0

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

13.0

12.9

JJ1AT

NOMESCO Finland

Puncture of lesion of liver with ultrasound guidance

22.6

12.9

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

12.8

548

7279

JFB00

NOMESCO Finland

Partial resection of small intestine

3.4

12.8

129

L04AX01

ATC

azathioprine; systemic

2.2

12.7

101

459

K29.6

ICD-10 Finland

Other gastritis

3.4

12.6

135

H01CB03

ATC

lanreotide; parenteral

70.2

12.6

C50

ICD-10 Finland

Malignant neoplasm of breast

70.2

12.6

SPAT1269

SPAT

Other puncture and/or drainage

5.5

12.6

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

12.5

154

824

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

11.0

12.5

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

12.5

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

12.5

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

12.5

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

12.5

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

12.5

C90.0

ICD-10 Finland

Multiple myeloma

+∞

12.5

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

+∞

12.5

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

12.5

YX9AW, ,

NOMESCO Finland

+∞

12.5

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

12.5

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

12.5

TQW20

NOMESCO Finland

Tatoe

+∞

12.5

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

12.5

8010/3-C22.0

ICD-O-3

Carcinoma, NOS, of liver

+∞

12.5

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

+∞

12.5

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

12.5

L01BC04

ATC

carmofur; oral

+∞

12.5

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

12.5

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

12.5

8246/3-C80.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of unknown primary site

+∞

12.5

ZX121

NOMESCO Finland

Central venous catheter

17.4

12.5

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

130.6

12.4

N06DA02

ATC

donepezil; oral

0.4

12.4

1720

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

37.7

12.2

JK3MB

NOMESCO Finland

Postoperative cholangiography

26.8

12.0

D13

ICPC

Jaundice

21.4

12.0

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.8

12.0

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.6

11.9

106

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

11.9

395

B01AF01

ATC

rivaroxaban; oral

0.6

11.8

157

2720

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

3.2

11.8

146

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

0.7

11.8

426

5848

R4110, ,

SPAT

0.5

11.7

129

2362

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

11.7

146

786

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

65.2

11.6

K83.3

ICD-10 Finland

Fistula of bile duct

65.2

11.6

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.7

11.6

241

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

11.5

158

876

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.9

11.5

191

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

11.5

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

11.5

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

11.5

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

11.5

JK5ZT

NOMESCO Finland

Implantation of bile duct prosthesis with combined percutaneous transhepatic and endoscopic retrograde technic

+∞

11.5

L01AX03

ATC

temozolomide; systemic

+∞

11.5

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

11.5

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

11.5

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

11.5

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

11.5

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

11.5

YJ1CD

NOMESCO Finland

Very extensive CT examination of abdomen for dose design of radiotherapy

+∞

11.5

E34.0

ICD-10 Finland

Carcinoid syndrome

120.5

11.4

SPAT1110

SPAT

Measurement of pain intensity

4.5

11.4

D98

ICPC

Cholecystitis/cholelithiasis

4.5

11.4

A10BJ02

ATC

liraglutide; parenteral

2.4

11.4

339

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

11.4

128

665

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

35.2

11.3

WX419

NOMESCO Finland

Other general anesthesy

4.0

11.2

A07AA09

ATC

vancomycin; oral

3.1

11.2

151

K70.0

ICD-10 Finland

Alcoholic fatty liver

3.5

11.1

106

JLB12

NOMESCO Finland

Transduodenal endoscopic incision of pancreatic duct orifice

25.1

11.1

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.9

11.0

168

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

11.0

1133

9515

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.4

11.0

112

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

10.9

442

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

43.5

10.9

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

10.8

760

6034

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.7

10.8

203

TQW99

NOMESCO Finland

Other minor procedure on skin

2.1

10.8

457

OAB43, ,

SPAT

0.5

10.8

1898

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.2

10.8

128

A06AH05

ATC

naldemedine; oral

28.1

10.7

SPAT1111

SPAT

Planning of analgesia

3.4

10.7

114

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

10.7

146

810

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.0

10.7

150

WPA42

NOMESCO Finland

Family-centered psychosocial intervention in palliative care

60.2

10.6

UJK52

NOMESCO Finland

Endoscopy of biliary tract in connection with endoscopic retrograde cholangiopancreatography

60.2

10.6

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.7

10.6

302

4353

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

10.6

221

1383

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

10.5

146

814

L04AA18

ATC

[U] everolimus

110.4

10.4

L04AH02

ATC

everolimus; oral

110.4

10.4

V03AF03

ATC

calcium folinate; systemic

110.4

10.4

JJ2CT

NOMESCO Finland

Biopsy of liver with CT guidance

110.4

10.4

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

10.4

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

10.4

L02BB04

ATC

enzalutamide; oral

+∞

10.4

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

10.4

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

10.4

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

10.4

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

10.4

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

10.4

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

10.4

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

10.4

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

10.4

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

10.4

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

10.4

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

10.4

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

10.4

L01CB01

ATC

etoposide; systemic

+∞

10.4

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

10.4

L02BX02

ATC

degarelix; parenteral

+∞

10.4

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

10.4

251

1626

C07AA05

ATC

propranolol; systemic

1.5

10.3

395

2825

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

4.9

10.3

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

18.8

10.3

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

10.2

559

4260

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

4.6

10.2

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

23.4

10.2

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.0

10.2

117

612

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

10.2

570

7291

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.7

10.1

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

10.0

170

1005

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.7

10.0

317

4481

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

40.2

10.0

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

10.0

174

1038

J01FF01

ATC

clindamycin; systemic

1.4

9.9

628

4898

A07EC02

ATC

mesalazine; oral, rectal

1.9

9.9

115

605

TPX15

NOMESCO Finland

Removal of vascular injection port

12.2

9.8

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.7

9.8

268

3904

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.4

9.8

N06DA03

ATC

rivastigmine; oral, transdermal

0.4

9.7

1174

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

55.2

9.6

L02BG03

ATC

anastrozole; oral

55.2

9.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

9.6

172

1032

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.5

9.6

252

ZY010

NOMESCO Finland

Hospital outpatient

2.2

9.6

392

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

9.6

107

556

UJF02

NOMESCO Finland

Peroral enteroscopy

4.5

9.5

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

8.4

9.5

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

4.0

9.5

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

7.1

9.5

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.4

9.5

266

R01AD58

ATC

fluticasone, combinations; nasal

0.6

9.5

199

3070

OAA67, ,

SPAT

0.4

9.4

1189

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

100.4

9.4

JJ4AT

NOMESCO Finland

Catherisation of liver lesion with ultrasound guidance

30.1

9.4

WPA43

NOMESCO Finland

A doctor's home visit to perform palliative care

30.1

9.4

JG1CG

NOMESCO Finland

Extensive MRI of rectum

17.6

9.4

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

17.6

9.4

S77

ICPC

Malignant neoplasm of skin

17.6

9.4

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

+∞

9.4

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

9.4

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

+∞

9.4

1990X

ICD-9 Finland

Malignant neoplasm without specification of site, Disseminated

+∞

9.4

128

Kela drug reimbursment

Cancers of female genital organs

+∞

9.4

8010/3-C80.9

ICD-O-3

Carcinoma, NOS, of unknown primary site

+∞

9.4

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

9.4

C25.7

ICD-10 Finland

Malignant neoplasm: Other parts of pancreas

+∞

9.4

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

9.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

9.4

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

9.4

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

9.4

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

9.4

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

9.4

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

9.4

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

9.4

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

12.4

9.3

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.0

9.3

140

K86.1

ICD-10 Finland

Other chronic pancreatitis

3.2

9.3

109

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

10.7

9.3

A28

ICPC

Limited function/disability NOS

1.4

9.2

572

4441

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

9.2

122

670

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

3.1

9.2

125

L15

ICPC

Knee symptom/complaint

0.7

9.2

332

4587

WZC00, ,

SPAT

0.6

9.1

156

2532

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

4.8

9.1

D69.5

ICD-10 Finland

Secondary thrombocytopenia

11.5

9.1

KC1GB

NOMESCO Finland

Cystography with X-ray

15.6

9.0

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

15.6

9.0

ZZA00

NOMESCO Finland

Split skin graft

2.3

9.0

285

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.0

9.0

100

519

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.6

9.0

200

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.7

8.9

183

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

18.6

8.9

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.2

8.9

112

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

24.1

8.9

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

24.1

8.9

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

8.9

105

556

ZX120, ,

SPAT

2.7

8.9

172

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

8.9

265

1801

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.9

8.9

102

535

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

8.8

580

7276

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

8.8

432

ZXE70

NOMESCO Finland

Moren than 15 and less than 18 hours

8.0

8.8

WX610

NOMESCO Finland

Patient controlled analgesia

6.8

8.8

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

6.8

8.8

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

8.8

193

1222

E83.50

ICD-10 Finland

Hypercalcemia

3.1

8.8

113

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

8.7

517

RD210, ,

NOMESCO Finland

3.0

8.7

124

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

8.7

277

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

14.1

8.7

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

50.1

8.7

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

50.1

8.7

JLA00

NOMESCO Finland

Exploration of pancreas

50.1

8.7

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.7

8.7

163

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.3

8.7

290

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

0.6

8.6

130

2180

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

8.6

125

707

F03

ICD-10 Finland

Unspecified dementia

0.5

8.6

1253

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.7

8.6

164

358

Kela drug reimbursment

liraglutide

4.1

8.5

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

27.6

8.5

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

27.6

8.5

K56.7

ICD-10 Finland

Ileus, unspecified

2.5

8.5

206

A10AD05

ATC

insulin aspart; parenteral

2.1

8.4

359

T73

ICPC

Neoplasm endocrine other/unspecified

90.3

8.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

90.3

8.4

C25

ICD-10 Finland

Malignant neoplasm of pancreas

90.3

8.4

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

8.4

301

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

7.9

8.4

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

8.3

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

8.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

8.3

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

8.3

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

8.3

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

8.3

8010/3-C23.9

ICD-O-3

Carcinoma, NOS, of gallbladder

+∞

8.3

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

8.3

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

8.3

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

8.3

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

8.3

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

+∞

8.3

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

8.3

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

8.3

JJA40

NOMESCO Finland

Excision of lesion of liver

+∞

8.3

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

8.3

K62.7

ICD-10 Finland

Radiation proctitis

+∞

8.3

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

8.3

1560A

ICD-9 Finland

Malignant neoplasm of gallbladder and extrahepatic bile ducts, Gallbladder

+∞

8.3

1551A

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Intrahepatic bile ducts

+∞

8.3

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

8.3

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

8.3

TDA90, ,

SPAT

0.5

8.3

1292

P15

ICPC

Chronic alcohol abuse

2.2

8.3

315

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.6

8.2

185

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

8.2

161

991

NG1AA, ,

SPAT

0.3

8.2

826

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

4.2

8.2

K51.8

ICD-10 Finland

Other ulcerative colitis

3.0

8.2

118

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

6.5

8.2

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

8.2

113

631

PC1CC

NOMESCO Finland

Very extensive angiography of aorta and abdominal arteries

7.5

8.1

E83.1

ICD-10 Finland

Disorders of iron metabolism

4.8

8.1

I85

ICD-10 Finland

Oesophageal varices

33.4

8.1

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

33.4

8.1

QX9VV, ,

NOMESCO Finland

33.4

8.1

XX1AD

NOMESCO Finland

Other CT-examination

33.4

8.1

JFC00

NOMESCO Finland

Entero-enterostomy

17.2

8.1

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.0

8.0

114

K82.9

ICD-10 Finland

Disease of gallbladder, unspecified

8.9

8.0

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

10.0

8.0

K76.6

ICD-10 Finland

Portal hypertension

22.1

8.0

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

22.1

8.0

D02

ICPC

Abdominal pain epigastric

1.8

8.0

124

716

AXX01, ,

SPAT

0.4

8.0

844

UJD02

NOMESCO Finland

Gastroscopy

1.7

7.9

127

741

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.7

7.9

A10BD07

ATC

metformin and sitagliptin; systemic

1.8

7.9

125

727

WPA13, ,

SPAT

13.1

7.9

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

7.8

487

SPAT1088

SPAT

Blood transfusion

6.1

7.8

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.4

7.8

1005

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.6

7.8

115

1939

K31.5

ICD-10 Finland

Obstruction of duodenum

10.8

7.8

JMA10

NOMESCO Finland

Transabdominal total splenectomy

9.4

7.8

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

9.4

7.8

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

7.8

590

4710

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

7.7

1192

SPAT1122

SPAT

Ascites puncture

45.1

7.7

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

45.1

7.7

WPA40

NOMESCO Finland

Individual-centered psychosocial intervention in palliative care

45.1

7.7

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

6.4

7.7

OAB42, ,

SPAT

0.6

7.6

136

2184

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

4.0

7.6

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

18.4

7.6

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

7.6

116

668

N03AX16

ATC

[U] pregabalin

1.3

7.6

501

3920

JCA20

NOMESCO Finland

Ligature of oesophageal varices

25.1

7.6

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

25.1

7.6

L08

ICPC

Shoulder symptom/complaint

0.7

7.5

313

4230

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

10.0

7.5

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

7.5

138

837

K65.0

ICD-10 Finland

Acute peritonitis

2.8

7.5

130

K74.0

ICD-10 Finland

Hepatic fibrosis

7.1

7.5

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.7

7.5

JKD30

NOMESCO Finland

Extrahepatic anastomosis of right or left hepatic duct to jejunum

80.3

7.4

XW2AT

NOMESCO Finland

Cytology of deep organ with ultrasound quidance

80.3

7.4

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

80.3

7.4

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

80.3

7.4

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

7.4

240

1660

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.5

7.4

B02AA02

ATC

tranexamic acid; systemic

1.5

7.4

207

1390

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.7

7.3

143

JHA00

NOMESCO Finland

Anal or perianal incision

3.1

7.3

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

3.1

7.3

OAA41

NOMESCO Finland

Health check based on individual needs

+∞

7.3

8500/3-C25.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of head of pancreas

+∞

7.3

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

7.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

7.3

JJB00

NOMESCO Finland

Wedge resection of liver

+∞

7.3

C25.3

ICD-10 Finland

Malignant neoplasm: Pancreatic duct

+∞

7.3

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

7.3

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

7.3

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

7.3

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

7.3

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

7.3

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

7.3

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

7.3

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

7.3

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

7.3

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

7.3

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

+∞

7.3

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

7.3

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

7.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

7.3

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

7.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

7.3

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

7.3

1552A

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUM HEPATIS, PRIMARIUM ALIUD]

+∞

7.3

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

7.3

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

7.3

L01CA04

ATC

vinorelbine; systemic

+∞

7.3

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

7.3

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

+∞

7.3

PJD98

NOMESCO Finland

Other block dissection of lymph nodes

+∞

7.3

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

7.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

7.3

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.6

7.3

119

1953

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.9

7.3

110

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.7

7.2

224

3192

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

15.8

7.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

7.2

266

1888

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.8

7.2

538

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

0.4

7.2

873

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.7

7.2

126

755

M05BX04

ATC

denosumab; parenteral

1.7

7.2

117

687

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

2.9

7.2

111

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.3

7.2

561

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

30.1

7.1

JK3AT

NOMESCO Finland

Catherisation of bile duct with ultrasound guidance

20.1

7.1

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

6.6

7.1

N05BA04

ATC

oxazepam; oral

1.3

7.1

605

4900

M25.5

ICD-10 Finland

Pain in joint

0.7

7.1

425

5427

V03AE01

ATC

polystyrene sulfonate; oral

2.5

7.1

169

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

12.0

7.1

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.4

7.1

206

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

8.8

7.0

JFF10

NOMESCO Finland

Loop enterostomy

8.8

7.0

L03

ICPC

Low back symptom/complaint

0.7

7.0

384

4971

H02

ICPC

Hearing complaint

0.7

7.0

228

3220

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

7.0

164

1058

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

7.0

157

1003

B82

ICPC

Anaemia other/unspecified

1.9

6.9

415

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.7

6.9

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

6.9

433

3359

L01

ICPC

Neck symptom/complaint

0.6

6.9

160

2417

207

Kela drug reimbursment

Chronic arrhythmias

0.7

6.9

319

4237

T93

ICPC

Lipid disorder

0.5

6.8

1232

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

6.7

6.8

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

9.3

6.8

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

40.1

6.8

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

40.1

6.8

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

16.7

6.7

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.6

6.7

150

KGH10

NOMESCO Finland

Operation for phimosis

1.9

6.6

407

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

6.6

170

1119

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.5

6.6

151

G04CA52

ATC

tamsulosin and dutasteride; systemic

0.7

6.6

211

2989

L13

ICPC

Hip symptom/complaint

0.7

6.6

271

3672

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.2

6.6

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

3.5

6.6

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.3

6.5

DAX08

NOMESCO Finland

Fitting of hearing aid

0.5

6.5

1265

I86.4

ICD-10 Finland

Gastric varices

10.0

6.5

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.7

6.5

315

4159

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

2.7

6.5

129

G04CB02

ATC

dutasteride; oral

0.6

6.5

134

2077

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.9

6.5

411

G20

ICD-10 Finland

Parkinson disease

0.4

6.5

736

M79.6

ICD-10 Finland

Pain in limb

0.8

6.5

703

8330

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

70.0

6.4

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

70.0

6.4

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

70.0

6.4

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

70.0

6.4

L02BG06

ATC

exemestane; oral

70.0

6.4

JA3GT

NOMESCO Finland

Insertion of tunnelled ascites drain

70.0

6.4

6603

FHL

Delete a block

70.0

6.4

WPA12

NOMESCO Finland

A meeting to support loved ones after the patient's death

70.0

6.4

R83

ICPC

Respiratory infection other

0.7

6.4

194

2779

Z94.0

ICD-10 Finland

Kidney transplant status

3.4

6.4

SPAT1053

SPAT

Memory test

0.7

6.4

270

3645

JLC10

NOMESCO Finland

Distal pancreatectomy

14.3

6.4

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

6.4

413

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

3.7

6.4

R01AD59

ATC

mometasone, combinations; nasal

0.3

6.3

568

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

6.5

6.3

N05BA06

ATC

lorazepam; systemic, sublingual

1.6

6.3

130

813

A10BH02

ATC

vildagliptin; oral

2.0

6.3

296

D01

ICPC

Abdominal pain/cramps general

1.5

6.3

222

1562

Z31.5

ICD-10 Finland

Genetic counselling

2.1

6.3

256

M01AH05

ATC

etoricoxib; oral

0.8

6.3

1053

11924

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

9.3

6.3

K03.64

ICD-10 Finland

Dental calculus supragingival

0.7

6.3

349

4512

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

6.3

C26.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of digestive system

+∞

6.3

8010/3-C24.9

ICD-O-3

Carcinoma, NOS, of billiary tract, NOS

+∞

6.3

3063, ,

Kela drug reimbursment

+∞

6.3

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

+∞

6.3

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

6.3

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

6.3

1562A

ICD-9 Finland

Malignant neoplasm of gallbladder and extrahepatic bile ducts, Ampulla of Vater

+∞

6.3

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

6.3

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

6.3

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

+∞

6.3

C80.9

ICD-10 Finland

Malignant neoplasm, primary site unspecified

+∞

6.3

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

6.3

8163/3-C24.1

ICD-O-3

Pancreatobiliary type carcinoma of ampulla of Vater

+∞

6.3

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

6.3

JDE01

NOMESCO Finland

Laparoscopic gastroenterostomy

+∞

6.3

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

6.3

L01EN02

ATC

pemigatinib; oral

+∞

6.3

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

6.3

XX7GT

NOMESCO Finland

Selective internal radio therapy (SIRT) with Yttrium

+∞

6.3

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

6.3

8010/3-C22.1

ICD-O-3

Carcinoma, NOS, of intrahepatic bile duct

+∞

6.3

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

6.3

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

6.3

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

+∞

6.3

C48.80

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum without histology

+∞

6.3

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

6.3

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

6.3

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

6.3

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

6.3

8180/3-C22.0

ICD-O-3

Combined hepatocellular carcinoma and cholangiocarcinoma of liver

+∞

6.3

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

6.3

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

6.3

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

6.3

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

6.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

6.3

XW2BT

NOMESCO Finland

Other cytological test with X-ray guidance

+∞

6.3

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

6.3

9120/3-C22.0

ICD-O-3

Hemangiosarcoma of liver

+∞

6.3

C49.49

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor

+∞

6.3

WGA10

NOMESCO Finland

Measurement of pain intensity

+∞

6.3

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.6

6.2

152

990

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

26.7

6.2

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

7.0

6.2

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.1

6.2

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

1.8

6.2

527

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

0.6

6.2

1532

UKC02

NOMESCO Finland

Cystoscopy

1.3

6.2

408

3188

A41.4

ICD-10 Finland

Sepsis due to anaerobes

5.3

6.1

WZC30, ,

SPAT

0.6

6.1

1516

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

6.1

356

2731

SPAT1290

SPAT

Preparation of deceased person

12.5

6.1

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

12.5

6.1

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

2.0

6.0

322

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

10.0

6.0

3AC01, ,

NOMESCO Finland

3.2

6.0

OAB48, ,

SPAT

0.5

6.0

1142

XX9XW, ,

NOMESCO Finland

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007566) Smooth muscle Ab [Titer] in Serum

488

550

10.48

307.65

1.5

1.2

104.21

113.40

titre

0.09

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1142

2334

7.46

307.65

9.8

2.2

28.00

8.05

umol/l

24.39

1080

2032

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

734

262

37.29

307.65

5.1

1.9

1055.86

28.98

u/ml

3.83

693

239

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1090

464

37.25

307.65

5.1

1.8

1964.73

288.78

u/ml

1.75

1002

370

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1668

1273

29.87

307.65

5.4

1.4

37.30

2.85

ug/l

3.30

1502

959

(40768441) Liver Pathology biopsy report

527

93.31

307.65

1.7

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

483

563

10.11

307.65

1.5

1.1

556.67

1606.67

titre

—

(3023183) Ammonium ion [Moles/volume] in Plasma

584

549

13.10

307.65

4.6

2.5

42.14

35.45

umol/l

2.58

548

488

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

291

106

30.43

307.65

1.5

1.3

—

(4035726) Immunohistochemistry procedure

660

560

15.00

307.65

1.6

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1164

1907

9.58

307.65

5.4

2.0

0.17

0.20

g/l

18.79

1103

1729

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

329

276

13.33

307.65

1.3

1.1

1.66

1.54

g/l

3.30

311

241

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

167

65.61

303.65

3.7

2.4

2184.75

5.15

ug/l

1.93

167

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

728

1732

5.29

295.71

1.7

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

857

2397

4.67

284.62

10.1

6.8

8.55

11.55

mmol/l

22.74

831

2265

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1620

7287

3.81

271.01

6.4

2.4

71.00

60.69

u/l

0.81

1578

6699

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2117

11390

4.27

269.93

26.3

3.9

26.96

12.67

umol/l

36.17

2091

10705

(3017143) Hepatitis C virus Ab [Presence] in Serum

672

1610

5.14

268.87

1.6

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1997

10373

4.04

267.04

14.6

4.0

31.33

35.19

g/l

135.23

1940

9555

(3033658) Prothrombin time (PT) actual/Normal

1333

5369

3.77

261.90

13.6

3.8

75.87

82.89

20.11

1311

5237

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1499

6893

3.46

232.29

10.9

2.7

65.63

37.67

u/l

10.47

1456

6423

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1017

3694

3.71

228.40

5.3

2.5

0.77

0.82

mmol/l

32.90

983

3405

(3023487) Leukocytes [#/volume] in Peritoneal fluid

150

22.88

204.47

2.0

2.8

5765.20

806.62

e6/l

0.50

109

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

659

1933

4.13

199.03

6.2

2.2

44.71

40.76

u/l

0.35

593

1588

(3023368) Bacteria identified in Blood by Culture

1458

7117

3.13

194.86

7.0

4.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

202

181

11.93

194.50

1.6

1.1

—

(3032080) INR in Blood by Coagulation assay

2033

12031

3.36

192.96

21.8

20.2

1.28

1.39

inr

20.08

1750

10149

(3044640) Blood type and Crossmatch panel - Blood

1368

6647

3.02

180.82

4.2

2.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

463

1128

4.70

177.25

1.7

1.4

1.39

1.15

g/l

2.37

422

1023

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

123

22.90

168.12

1.9

2.8

2570.06

40615.87

e6/l

0.59

(3033799) Differential panel - Peritoneal fluid

123

22.11

165.72

2.1

1.7

—

(3044007) Cell count panel - Peritoneal fluid

122

21.19

161.47

2.0

1.9

—

(3002256) Pathology report gross observation

536

1572

3.96

159.44

1.5

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1106

5075

2.92

157.68

4.1

2.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

501

1421

4.06

156.00

2.3

2.2

12.66

10.85

g/l

10.94

458

1301

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1656

9621

2.70

145.45

4.8

2.5

—

estimate

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

377

968

4.33

133.36

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

667

2506

3.16

133.04

3.9

2.2

256.39

234.16

u/l

1.71

649

2326

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

204

304

7.15

131.58

7.7

5.3

1120.31

480.88

iu/ml

1.12

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

850

3675

2.86

131.58

2.8

22.43

22.23

0.13

829

3357

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

107

17.33

129.28

3.9

2.0

0.59

0.61

mmol/l

0.93

107

(3042936) Bacteria identified in Isolate by Culture

789

3315

2.90

128.45

2.7

2.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

249

469

5.72

127.19

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1849

11872

2.56

123.79

19.3

6.2

4.37

4.45

e9/l

0.56

1669

10042

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

257

511

5.43

123.67

4.4

2.2

3.04

3.52

g/l

4.04

250

485

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

571

2047

3.23

122.45

2.3

1.8

1.64

1.59

1.07

495

1733

(3026692) Albumin [Mass/volume] in Peritoneal fluid

102

16.75

121.24

1.6

2.0

10.97

13.77

g/l

1.22

(3042733) HLA Ab [Presence] in Serum

17.64

120.78

1.5

4.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

872

3993

2.70

119.07

2.7

2.28

2.26

g/l

0.50

829

3620

(3022948) Iron [Moles/volume] in Serum or Plasma

909

4284

2.64

116.77

2.9

2.7

12.21

12.45

umol/l

0.42

879

3916

(3002331) Protein [Mass/volume] in Peritoneal fluid

21.59

115.06

1.2

1.3

40.69

27.56

g/l

0.30

(3024471) HLA-A [Type]

18.93

113.62

1.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

281

650

4.68

113.00

1.6

1.5

171.38

281.94

ug/g

13.77

175

412

(3024932) HLA-DR beta [Type]

19.10

112.84

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

123

119

10.75

111.96

2.3

2.2

31.07

44.95

iu/ml

0.38

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

139

173

8.39

104.60

1.4

1.3

149.00

166.00

titre

0.08

(3018677) aPTT in Platelet poor plasma by Coagulation assay

823

3881

2.57

103.75

3.0

1.9

31.62

29.87

8.16

808

3774

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

170

271

6.60

102.62

1.3

1.4

150.71

153.78

au/ml

0.09

100

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

180

314

6.05

99.30

1.4

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

713

3197

2.64

99.18

7.0

5.7

1.05

1.04

mmol/l

0.24

678

2924

(3026250) Tacrolimus [Mass/volume] in Blood

13.94

99.17

43.0

35.6

6.73

7.25

ug/l

1.27

(3006922) Hepatitis E virus Ab [Presence] in Serum

119

130

9.51

99.16

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

169

283

6.28

97.15

1.3

1.2

331.25

284.74

u/ml

0.82

114

166

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

178

314

5.98

97.05

1.4

1.3

—

18.26

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

112

119

9.75

95.26

1.1

1.0

—

(40768804) Tissue Pathology biopsy report

1133

6392

2.28

93.56

2.7

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

183

356

5.42

89.79

1.2

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

408

1425

3.17

89.68

12.4

9.7

15.61

16.02

1.98

396

1383

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

423

1531

3.07

87.33

13.1

8.2

24.13

24.84

mmol/l

3.50

417

1517

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

142

223

6.65

86.84

2.8

2.6

356.60

273.37

u/ml

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

240

601

4.27

86.72

6.3

2.9

1.65

1.78

mg/l

1.21

221

519

(3016650) Hepatitis A virus Ab [Presence] in Serum

156

270

6.05

86.64

1.1

1.0

—

(4281824) Cell count and differential, peritoneal fluid

100

10.11

85.79

1.3

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

446

1680

2.96

85.69

13.4

9.1

95.01

93.39

8.11

446

1672

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1622

10824

2.15

85.03

10.7

6.0

1.19

1.21

mmol/l

14.95

1568

9802

(3048929) Epstein Barr virus Ab [Presence] in Serum

187

390

5.06

84.73

1.4

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

287

831

3.73

84.65

2.7

1.5

0.25

0.31

mg/l

1.11

107

382

(3002173) Hemoglobin [Mass/volume] in Arterial blood

587

2568

2.62

84.47

12.0

7.6

116.54

121.97

g/l

8.34

574

2516

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

283

817

3.73

83.81

3.4

2.8

0.29

0.34

iu/ml

1.97

134

474

(3019977) pH of Arterial blood

666

3108

2.49

83.57

11.1

7.0

7.42

0.23

306

1802

(3016502) Oxygen saturation in Arterial blood

621

2814

2.54

82.91

11.4

7.1

96.76

94.84

15.46

604

2714

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1751

12111

2.14

82.57

11.2

6.3

1.19

1.21

mmol/l

16.08

1544

10386

(3021162) Amylase [Enzymatic activity/volume] in Specimen

149.46

82.48

3.6

4.8

416.73

779.33

u/l

—

(3027801) Oxygen [Partial pressure] in Arterial blood

666

3131

2.47

82.08

11.1

7.0

13.01

11.43

kpa

13.68

642

2998

(3000991) Gas panel - Venous blood

529

2228

2.68

81.99

13.6

8.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

665

3131

2.46

81.64

11.1

7.0

5.02

5.05

kpa

0.47

643

3003

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

156

286

5.71

81.55

1.1

1.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

544

2339

2.64

80.79

11.7

7.0

1.74

1.43

mmol/l

3.92

532

2280

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

437

1687

2.88

79.95

1.8

1.6

—

(3003396) Base excess in Arterial blood by calculation

657

3110

2.44

79.47

11.1

6.9

0.37

1.12

mmol/l

5.14

556

2533

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1864

13309

2.14

79.46

10.8

3.2

224.78

51.48

u/l

92.15

1789

12189

(3015377) Calcium [Moles/volume] in Serum or Plasma

1229

7524

2.11

79.13

7.0

2.2

2.33

2.35

mmol/l

3.66

1176

6580

(3018418) pH of Serum or Plasma

1154

7053

2.06

73.14

5.4

3.5

7.41

7.40

5.80

889

5093

(3013826) Glucose [Moles/volume] in Serum or Plasma

1920

14104

2.09

72.60

11.9

4.9

7.41

6.92

mmol/l

15.23

1877

13411

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

425

1699

2.76

72.37

13.7

8.9

1.34

1.35

0.10

425

1686

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

233

650

3.81

72.29

1.9

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

105

162

6.69

65.21

1.1

1.0

283.93

286.32

mg/l

0.09

146

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

12.86

64.98

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

377

1494

2.75

64.92

14.7

9.1

23.80

24.30

mmol/l

2.27

371

1445

(3010375) cycloSPORINE [Mass/volume] in Blood

10.68

64.90

32.6

28.5

133.49

126.65

ug/l

0.25

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

179

446

4.21

64.83

2.2

1.5

129.04

26.80

u/ml

3.16

173

423

(42870588) Differential panel, method unspecified - Blood

1160

7358

1.97

63.97

7.3

5.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

145

317

4.76

61.96

2.1

1.7

0.87

0.95

g/l

0.31

113

249

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

301

1083

2.99

61.90

2.2

1.7

2.49

1.61

ug/l

0.71

285

932

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

151

346

4.55

60.89

7.0

5.9

12.06

12.37

mg/l

0.28

140

319

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2157

17027

2.07

60.64

29.0

5.8

180.25

77.82

u/l

121.19

2120

15849

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

14.85

60.55

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

825

4721

2.05

60.27

6.8

2.2

2.51

2.45

mmol/l

27.15

778

4132

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

117

7.55

59.87

1.2

90.25

84.00

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

27.03

58.27

2.3

1.4

60.77

54.90

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

786

4479

2.04

57.69

2.2

1.9

—

(3003694) ABO and Rh group [Type] in Blood

893

5372

1.96

55.86

1.5

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

1054

6723

1.90

55.10

4.0

3.2

0.85

0.49

e6/l

2.79

828

4976

(3002030) Lymphocytes/Leukocytes in Blood

1452

10284

1.83

53.97

8.0

5.7

22.57

26.13

26.65

1398

9613

(3019069) Monocytes/Leukocytes in Blood

1434

10141

1.83

53.35

8.1

5.7

9.47

9.19

2.30

1365

9350

(3018010) Neutrophils/Leukocytes in Blood

1424

10111

1.81

51.69

7.8

5.6

61.32

58.51

13.17

1372

9548

(40768797) Stomach Pathology biopsy report

583

3098

2.11

50.91

1.4

1.2

—

(3006504) Eosinophils/Leukocytes in Blood

1419

10128

1.79

50.04

8.1

5.6

2.52

3.00

14.06

1353

9345

(3022096) Basophils/Leukocytes in Blood

1414

10135

1.78

48.67

8.2

5.7

0.57

0.65

6.97

1345

9347

(3002582) Erythrocytes [#/volume] in Urine

1165

7895

1.80

48.51

4.2

3.3

155.66

69.94

e6/l

0.42

939

6058

(3021447) Carbon dioxide [Partial pressure] in Venous blood

545

2875

2.11

48.27

5.1

3.5

5.56

5.84

kpa

8.50

538

2788

(46235355) HIV 1 and 2 tests - Meaningful Use set

430

2090

2.24

46.76

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

1534

11343

1.76

46.60

7.9

5.5

1.55

1.81

e9/l

17.65

1361

9750

(3002032) Base excess in Venous blood by calculation

532

2815

2.09

46.59

5.2

3.5

1.14

1.88

mmol/l

4.32

439

2429

(3012544) pH of Venous blood

544

2923

2.06

45.63

5.2

3.5

7.38

0.31

349

1710

(3036489) Thrombin time

210

734

3.01

45.14

3.4

1.8

22.69

20.89

6.75

203

658

(3006315) Basophils [#/volume] in Blood

1507

11161

1.74

44.85

7.9

5.5

0.04

e9/l

5.62

1301

9397

(3001604) Monocytes [#/volume] in Blood

1500

11107

1.73

44.56

7.9

5.4

0.63

e9/l

0.48

1300

9338

(40768795) Lymph node Pathology biopsy report

12.40

44.46

1.2

1.1

—

(3026782) Osmolality of Urine

763

4648

1.87

44.14

3.6

2.9

533.80

537.24

mosm/kgh2o

0.17

702

4037

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

652

3779

1.94

43.90

3.4

3.1

2.15

2.06

e6/l

0.09

357

1888

(3037522) Nuclear Ab [Titer] in Serum

529

2861

2.04

43.38

1.5

1.3

362.35

512.75

titre

1.73

119

662

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

598

3390

1.96

42.86

2.1

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

567

3169

1.98

42.28

2.1

1.9

—

(3013115) Eosinophils [#/volume] in Blood

1527

11480

1.70

41.87

8.2

5.6

0.17

0.21

e9/l

15.72

1335

9795

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

8.11

40.98

1.8

1.4

2144627.50

1930639.80

iu/ml

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

101

6.56

40.07

1.6

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

582

9297

0.53

39.77

2.3

2.0

1.49

1.31

mmol/l

5.60

513

7671

(3007164) IgA [Mass/volume] in Serum or Plasma

623

3663

1.89

39.68

1.7

1.3

3.65

2.76

g/l

12.47

470

2052

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

147

5.43

39.50

1.0

—

(3018095) Leukocytes [#/volume] in Urine

1214

8736

1.67

38.00

4.9

3.9

82.70

126.27

e6/l

1.78

958

6236

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

684

4201

1.82

37.68

3.3

3.0

1.13

1.24

e6/l

0.29

387

2326

(3000850) Epithelial cells [#/volume] in Urine

831

5541

1.70

33.78

3.3

2.6

6.14

4.60

e6/l

3.04

782

5017

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

957

6636

1.66

33.47

2.9

2.5

3.50

2.83

mg/l

9.35

857

5656

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

438

2417

1.96

33.22

4.4

3.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

285

1373

2.19

31.10

1.6

1.5

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

6.72

31.03

2.8

1.3

25.57

28.15

umol/l

1.11

(3031040) Bacteria [#/volume] in Urine by Automated count

1819

14900

1.60

30.92

5.7

4.8

1255.34

2307.38

e6/l

0.66

261

(40758558) Short blood count panel - Blood

919

6479

1.62

29.21

12.9

4.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

107

336

3.27

27.53

1.2

—

(3026008) Bacteria identified in Urine by Culture

985

7233

1.55

25.48

3.4

3.5

—

(3004809) Band form neutrophils/Leukocytes in Blood

276

3.41

25.46

3.4

2.4

1.96

1.32

0.84

230

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

330

1828

1.91

24.34

4.8

3.1

1.21

1.22

mmol/l

2.59

304

1537

(3024354) Oxygen [Partial pressure] in Venous blood

409

2434

1.79

23.97

4.6

3.0

4.51

4.47

kpa

0.18

403

2349

(3008152) Bicarbonate [Moles/volume] in Arterial blood

324

1793

1.91

23.96

7.2

6.3

23.67

24.47

mmol/l

3.10

308

1728

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1873

21244

0.66

23.15

5.5

5.6

4.24

4.38

mmol/l

6.82

1695

19579

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

250

3.39

22.85

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1855

21065

0.66

22.85

5.4

5.5

1.29

1.41

mmol/l

25.17

1659

19264

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

198

3.70

22.74

1.1

1.2

58.08

52.14

u/l

0.43

173

(3017181) Myelocytes/Leukocytes in Blood

329

1863

1.86

22.61

4.7

3.8

1.18

0.75

2.09

184

417

(3019060) Gas panel - Arterial blood

309

1721

1.89

22.35

5.3

4.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

327

1855

1.86

22.33

4.0

2.4

65.83

61.94

ml/min/173m2

0.76

152

759

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1933

21719

0.66

21.86

6.0

6.5

2.43

2.52

mmol/l

3.68

1735

19964

(3012501) Base excess in Blood by calculation

125

487

2.64

21.85

4.6

2.21

2.70

mmol/l

1.37

320

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

22.37

21.68

1.7

1.3

22.20

16.13

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

297

1652

1.89

21.54

1.9

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

328

1894

1.83

21.12

3.0

1.8

408.50

370.85

nmol/l

2.33

307

1711

(3045142) Bone marrow Pathology biopsy report

103

4.72

21.03

1.5

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

20.85

1.0

0.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

15.87

20.55

1.3

1.0

—

(3000494) Fungus identified in Specimen by Culture

423

2649

1.70

20.51

1.8

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

226

1168

2.01

20.31

6.5

4.4

0.85

0.86

0.02

212

1111

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

115

4.41

20.13

1.1

1.2

209.16

87.95

u/l

2.68

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

240

1271

1.97

20.12

6.3

4.3

1.72

1.58

1.25

228

1209

(3027945) Reticulocytes/Erythrocytes in Blood

491

3227

1.63

19.69

2.7

2.1

1.99

1.76

3.94

446

2826

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

110

4.42

19.42

1.1

1.2

50.26

20.77

u/l

1.90

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1904

21289

0.69

18.80

5.9

5.8

6.51

6.13

mmol/l

21.40

1724

19256

(3002179) Metamyelocytes/Leukocytes in Blood

305

1791

1.79

18.49

4.7

3.6

0.76

0.59

0.86

169

412

(3034274) Bile acid [Moles/volume] in Serum --fasting

4.54

18.45

4.5

1.4

62.06

6.35

umol/l

3.77

(40760892) CBC W Ordered Manual Differential panel - Blood

618

4366

1.53

17.97

5.4

4.3

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

16.62

17.84

1.2

1.6

1.70

0.71

ml/s/173m2

2.62

(3021589) Normoblasts [#/volume] in Blood

1187

9526

1.42

17.81

23.8

10.6

0.00

e9/l

0.91

946

7683

(21494434) Karyotype in Bone marrow

118

4.12

17.76

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1887

21038

0.70

17.20

9.5

7.5

42.74

40.66

mmol/mol

13.62

1739

19436

(3042111) Morphology [Interpretation] in Bone marrow Narrative

232

3.11

17.19

1.3

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1198

9705

1.40

16.69

3.8

3.1

202.52

142.47

ug/l

8.70

1125

8884

(3047181) Lactate [Moles/volume] in Blood

159

778

2.10

16.56

7.2

5.1

1.69

1.36

mmol/l

1.38

136

694

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

16.39

16.53

1.9

1.3

—

(3021440) Promyelocytes/Leukocytes in Blood

300

1814

1.73

16.37

4.9

3.8

0.15

0.06

1.24

159

371

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1805

20217

0.71

16.25

4.9

4.7

1.38

1.28

mmol/l

6.68

1610

18282

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

161

803

2.06

15.95

1.4

1.2

—

(3039000) Anion gap in Blood by calculation

117

515

2.33

15.81

8.5

5.9

11.91

11.43

mmol/l

0.67

105

468

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

117

515

2.33

15.81

1.5

1.6

—

(3018572) Chloride [Moles/volume] in Blood

117

515

2.33

15.81

8.5

5.9

105.79

104.88

mmol/l

1.73

105

468

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

15.74

15.69

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

107

4.06

15.68

2.3

1.5

—

(1761868) Lipid panel - Serum or Plasma

499

6948

0.66

15.57

4.0

3.7

—

(1616796) Gas panel - Central venous blood

122

552

2.26

15.46

3.7

4.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

190

3.20

15.34

2.6

2.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

196

3.16

15.23

1.8

1.5

19.74

23.87

ng/l

0.81

196

(3022145) Colonoscopy Study observation

347

2222

1.64

15.21

1.6

1.3

—

(3025159) Blasts/Leukocytes in Blood

299

1843

1.69

15.18

5.1

4.0

0.19

0.01

0.74

145

345

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

117

531

2.25

14.73

1.9

1.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

251

1489

1.75

14.62

3.8

2.7

1.19

1.17

0.19

251

1480

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

114

520

2.24

14.19

1.9

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

247

1478

1.73

13.95

3.9

2.7

0.66

0.62

1.40

247

1472

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

5.23

13.90

2.5

2.21

1.15

0.88

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

101

3.90

13.51

1.9

1.4

17.01

84.52

u/l

—

(3020891) Body temperature

227

1344

1.75

13.31

5.0

4.4

36.88

36.91

°c

0.60

227

1326

(3027135) IgG subclass 1 [Mass/volume] in Serum

191

3.02

13.29

1.5

1.4

7.70

7.01

g/l

0.43

144

(3024139) IgG subclass 3 [Mass/volume] in Serum

191

3.02

13.29

1.5

1.4

0.49

0.41

g/l

0.60

144

(3028192) IgG subclass 2 [Mass/volume] in Serum

191

3.02

13.29

1.5

1.4

3.27

3.05

g/l

0.27

143

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1810

20049

0.74

13.17

5.1

5.0

2.34

2.04

mu/l

6.13

1629

18186

(4062490) Immunoglobulin typing, IgG

187

3.03

13.14

1.6

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

219

1293

1.75

12.96

1.8

1.6

1.45

1.56

g/l

0.83

180

1114

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

124

614

2.07

12.57

1.5

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

334

2217

1.57

12.53

2.0

1.7

65.72

66.36

g/l

0.68

305

1980

(3017354) Segmented neutrophils/Leukocytes in Blood

204

2.88

12.44

3.3

2.3

59.34

60.09

0.09

164

(3023520) Reticulocytes [#/volume] in Blood

368

2507

1.54

12.29

2.8

2.1

74.31

67.23

e9/l

2.50

273

1870

(3007853) Bacteria identified in Skin by Aerobe culture

394

2734

1.51

12.06

1.9

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

111

542

2.09

11.70

1.6

1.5

—

(3025941) Bacteria identified in Stool by Culture

177

1013

1.80

11.66

1.2

—

(40768800) Prostate Pathology biopsy report

150

3.10

11.28

1.3

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

120

3.37

11.22

1.6

1.5

4.29

7.05

u/l

0.61

102

(3027273) Bicarbonate [Moles/volume] in Venous blood

225

1393

1.67

11.20

4.3

3.1

24.08

25.25

mmol/l

4.56

218

1337

(3037121) Protein [Mass/volume] in Urine

147

805

1.87

11.17

3.6

2.8

598.53

387.25

mg/l

0.32

309

(3035933) Granulocytes/Leukocytes in Blood

377

2.27

10.94

3.3

3.0

58.52

59.27

0.19

377

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

741

9186

0.74

10.94

4.0

22.45

24.58

2.83

356

4549

(40761536) Microorganisms panel - Urine sediment

249

1596

1.61

10.80

5.0

4.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

352

2.28

10.48

2.0

1.4

—

(3003181) Sodium [Moles/volume] in Urine

101

498

2.07

10.41

1.4

49.78

60.95

mmol/l

1.85

391

(3035715) Granulocytes [#/volume] in Blood

322

2.33

10.37

3.1

4.24

4.48

e9/l

0.25

322

(3028308) Erythrocytes [#/volume] in Pleural fluid

262

2.48

10.26

1.6

1.4

26334.58

59627.03

e6/l

0.67

149

(3052851) Hemolysis interference index of Serum or Plasma

118

626

1.92

9.91

4.2

3.7

2.42

1.67

index

0.49

315

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

251

3708

0.65

9.83

1.2

1.3

45.51

38.44

iu/ml

0.21

1092

(40768806) Pleura Pathology biopsy report

227

2.54

9.70

1.7

1.4

—

(40768793) Breast Pathology biopsy report

3.55

9.49

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

155

2.87

9.48

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

9.38

1.0

0.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

300

2.30

9.27

1.6

1.5

1074.10

2080.12

e6/l

0.64

213

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

658

5217

1.34

9.27

4.4

414.30

445.22

ng/l

0.08

572

4504

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.29

9.12

1.5

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

470

2.01

9.01

1.6

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

212

2.53

8.96

2.7

2.9

—

(44790047) Parainfluenza type 1 nucleic acid detection

262

2.36

8.86

1.6

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

262

2.36

8.86

1.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

262

2.36

8.86

1.6

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

262

2.36

8.86

1.6

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.67

8.71

2.4

2.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

258

2.35

8.70

1.8

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

4.26

8.65

2.0

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

512

6516

0.74

8.57

2.9

3.0

0.73

ug/l

0.07

356

4452

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

404

2.06

8.53

1.5

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

128

732

1.78

8.52

1.5

1.4

18.48

17.78

iu/ml

—

(3045788) Cell count panel - Pleural fluid

243

2.37

8.43

1.8

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1359

0.48

8.33

1.8

2.2

3.78

3.52

ratio

0.81

1134

(3000093) Morphology [Interpretation] in Blood Narrative

229

2.38

8.10

1.2

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1480

16394

0.80

7.93

4.3

4.0

14.94

15.03

pmol/l

0.60

1322

14759

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1173

10207

1.25

7.73

4.8

4.3

38.28

96.20

ng/l

2.28

1010

7973

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

154

954

1.65

7.70

1.4

1.2

—

(3004775) Volume in Urine collected for unspecified duration

216

2.39

7.69

2.2

2.3

843.77

623.12

2.30

130

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

245

3468

0.68

7.65

1.2

1.3

15.90

14.00

u/ml

0.12

1283

(3026493) Urate [Moles/volume] in Serum or Plasma

777

6444

1.28

7.65

3.8

2.6

370.00

365.13

umol/l

0.53

691

5475

(21494814) CD8 cells/Lymphocytes in Specimen

4.52

7.64

1.8

2.6

41.56

26.40

2.06

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

18.40

7.60

5.8

3.2

—

(3012441) Differential panel - Pleural fluid

249

2.27

7.56

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

250

2.26

7.50

1.7

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

225

2.34

7.48

3.9

3.6

18.95

12.18

index

1.38

110

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1058

9125

1.25

7.46

3.3

3.4

1454.65

1697.94

ng/l

0.92

944

7960

(3005988) Vibrio sp identified in Specimen by Organism specific culture

252

2.25

7.36

1.7

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

265

2.21

7.36

1.7

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

184

2.47

7.33

1.3

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

594

4798

1.30

7.11

2.5

1.7

2.70

1.38

mg/l

6.40

504

3773

(21494755) Public health laboratory ask at order entry panel

980

0.44

7.10

1.2

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

250

2.22

7.08

1.7

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

989

11340

0.80

6.86

4.6

4.4

2.15

2.14

ug/l

0.02

848

10196

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

154

2.55

6.85

1.6

12.19

15.03

umol/l

1.83

140

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

287

2.11

6.81

1.2

1.84

1.42

nmol/l

1.26

257

(3024522) Salmonella sp identified in Specimen by Organism specific culture

263

2.15

6.67

1.7

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

283

2.11

6.66

1.8

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

414

1.91

6.65

1.7

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

256

1836

1.43

6.56

4.1

3.8

4.91

5.18

kpa

6.08

243

1734

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

117

705

1.69

6.55

2.4

2.2

155.85

100.26

ug/min

0.49

408

(3009343) pH of Capillary blood

250

1786

1.44

6.54

4.1

3.8

7.42

7.41

0.87

217

1481

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

155

1003

1.58

6.53

2.1

1.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

341

1.99

6.46

1.6

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

260

2.14

6.46

1.7

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

128

795

1.64

6.39

4.0

4.2

3.93

3.95

mmol/l

0.18

128

786

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

+∞

6.25

1.0

0.0

17.67

—

umol/l

—

(3021374) Sirolimus [Mass/volume] in Blood

+∞

6.25

15.2

0.0

8.87

—

ug/l

—

(3010813) Leukocytes [#/volume] in Blood

2205

23171

0.79

6.23

59.9

24.8

7.31

6.86

e9/l

11.54

2147

22417

(3000963) Hemoglobin [Mass/volume] in Blood

2205

23171

0.79

6.23

60.4

24.9

122.54

135.60

g/l

223.24

2166

22800

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2205

23169

0.79

6.21

62.1

25.2

36.96

40.32

150.31

2163

22779

(3026361) Erythrocytes [#/volume] in Blood

2205

23169

0.79

6.21

59.8

24.7

4.13

4.47

e12/l

138.22

2145

22419

(3035941) MCH [Entitic mass]

2205

23168

0.79

6.20

59.6

24.6

30.28

30.53

6.90

2165

22787

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

497

1.79

6.20

1.2

1.4

0.74

0.82

nmol/l

0.48

405

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2205

23167

0.79

6.19

59.7

24.7

91.48

91.74

1.52

2167

22783

(3007461) Platelets [#/volume] in Blood

2205

23166

0.79

6.18

59.9

24.7

225.07

237.11

e9/l

8.80

2149

22528

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

550

1.75

6.16

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

550

1.75

6.16

1.5

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

175

2.36

6.14

1.0

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

957

0.48

5.98

1.6

1.9

3.32

3.44

mmol/l

0.32

725

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

133

855

1.58

5.80

2.2

2.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

462

1.78

5.56

1.4

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

219

1580

1.42

5.46

4.1

3.6

1.94

1.97

mmol/l

0.03

149

1124

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

141

2.43

5.45

1.6

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

141

933

1.54

5.43

1.8

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

2.96

5.41

1.2

22.01

32.89

u/l

0.87

(3009214) Lutropin [Units/volume] in Serum or Plasma

359

1.86

5.30

1.3

1.4

11.85

7.44

u/l

1.69

285

(3004588) Protein electrophoresis panel - Serum or Plasma

253

1885

1.38

5.23

1.9

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

144

2.38

5.22

1.6

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2199

23007

0.81

5.14

52.9

22.1

84.20

84.99

umol/l

0.37

2165

22630

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

177

2.22

5.13

1.9

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

161

1110

1.48

5.12

1.4

1.6

5.57

23.10

iu/ml

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

6.02

4.91

1.0

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

194

2.13

4.88

1.9

1.3

—

(1002224) Polysomnography panel

731

0.47

4.85

1.0

1.1

—

(3016750) Collection duration of Urine

137

2.35

4.82

2.2

2.0

503.45

491.72

min

0.34

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

120

789

1.54

4.80

2.0

1.4

0.00

g/l

-0.00

697

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

211

2.05

4.68

1.8

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

114

746

1.55

4.66

2.0

1.5

0.00

g/l

-0.00

694

(3037756) Immunofixation for Serum or Plasma

518

1.66

4.66

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.59

4.63

1.9

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.59

4.63

1.9

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

318

2499

1.31

4.61

3.2

3.4

206.41

242.67

ng/l

1.07

296

2315

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1949

20556

0.84

4.52

41.6

16.1

76.67

73.68

ml/min/173m2

7.99

1863

19052

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

277

1.89

4.50

1.2

171.78

204.66

miu/ml

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

254

1940

1.34

4.50

3.9

4.0

87.44

98.25

ng/l

1.50

226

1627

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

122

818

1.51

4.48

2.0

1.4

0.05

0.01

g/l

0.48

102

741

(3019225) pH of Specimen

297

2326

1.31

4.41

5.1

3.9

7.37

7.36

0.62

266

1543

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

124

2.35

4.41

1.7

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

125

2.33

4.34

2.1

1.8

128.78

36.63

umol/l

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

119

2.37

4.32

1.8

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

11.69

4.27

1.3

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

120

2.35

4.24

5.9

3.9

59.09

72.72

mg/l

0.57

(3041096) Erythrocytes [Presence] in Urine by Automated

697

6040

1.20

4.23

4.7

3.5

0.01

0.15

estimate

0.55

255

1851

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

121

821

1.49

4.22

2.6

1.5

1.72

1.68

ratio

0.05

487

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.51

4.21

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.51

4.21

1.5

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

372

0.32

4.20

1.0

1.2

1.38

1.50

g/l

0.78

372

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

158

1130

1.42

4.20

1.9

1.4

7.56

7.47

g/l

0.23

140

1000

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

157

1124

1.42

4.15

1.9

1.4

4.08

3.76

g/l

2.11

140

996

(1761482) Bacteria [#/volume] in Urine by Culture

102

671

1.54

4.12

4.7

4.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

202

1.99

4.07

1.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

132

919

1.46

4.06

2.6

1.5

37.13

35.46

mg/l

0.28

111

781

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

138

969

1.45

4.06

1.9

1.5

0.42

0.40

g/l

0.03

114

827

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

157

1129

1.41

4.05

1.9

1.4

4.32

4.18

g/l

1.35

140

1002

(3034860) Kappa light chains.free [Mass/volume] in Serum

132

920

1.46

4.04

2.6

1.5

53.63

50.10

mg/l

0.32

109

785

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

149

1064

1.42

4.00

1.9

1.4

2.97

2.92

g/l

0.24

131

936

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

163

2.10

3.97

1.8

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

163

2.10

3.97

1.8

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

163

2.10

3.97

1.8

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

140

992

1.43

3.93

1.9

1.4

11.38

10.26

g/l

1.59

120

856

(3017732) Neutrophils [#/volume] in Blood

331

2670

1.27

3.93

5.2

2.9

5.93

4.85

e9/l

0.64

293

2218

(3049717) Cytology report of Urine Cyto stain

124

859

1.46

3.92

2.7

1.8

—

(4094501) Cardiovascular stress test using bicycle ergometer

672

0.51

3.85

1.2

1.1

—

(3000012) Reticulocyte production index

375

1.70

3.83

1.8

1.6

1.06

0.88

1.06

245

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

153

2.10

3.78

1.4

1.3

17.53

14.47

u/l

1.00

146

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.54

3.63

2.2

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.54

3.63

2.2

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.54

3.63

2.2

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.54

3.63

2.2

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

6.17

3.50

1.1

3.5

—

(3042631) Mycobacterium sp identified in Specimen

302

1.74

3.48

2.3

3.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

140

2.08

3.37

1.7

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

126

903

1.41

3.37

1.6

1.8

46.92

38.66

u/l

2.95

110

760

(3013945) Hepatitis B virus e Ab [Presence] in Serum

7.01

3.36

2.0

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

313

1.71

3.36

2.2

20.37

20.53

mg/l

0.01

(3035880) pH of Pleural fluid

127

2.14

3.35

1.1

1.3

7.44

7.45

0.13

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.93

3.30

1.1

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.59

3.21

1.2

19.04

5.48

ug/l

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

141

1042

1.37

3.17

2.2

2.1

453.62

726.24

ug/l

0.47

136

994

(3015736) pH of Urine

1063

9721

1.15

3.15

4.2

3.6

6.24

6.27

0.35

567

5307

(3048689) Calprotectin [Mass/mass] in Stool

283

2303

1.25

3.15

2.8

2.3

220.01

176.30

ug/g

0.81

244

1832

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

100

1411

0.70

3.14

2.3

2.5

23.50

19.59

au/ml

—

(3019309) Folate [Moles/volume] in Red Blood Cells

585

5118

1.18

3.11

1.9

1.8

1171.47

1154.03

nmol/l

0.16

457

3845

(3039443) Prostate specific Ag panel - Serum or Plasma

468

0.49

3.08

1.1

1.6

—

(3008295) Osmolality of Serum or Plasma

246

1.76

3.07

1.1

1.4

280.12

274.89

mosm/kgh2o

0.62

181

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

229

0.35

3.04

1.1

1.8

—

(3035350) Ketones [Presence] in Urine by Test strip

1318

12254

1.14

3.03

4.8

4.0

7.99

2.41

estimate

0.49

340

2491

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1281

0.69

2.98

1.2

1.3

46.43

61.23

au/ml

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

962

0.65

2.98

1.2

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

241

1.75

2.98

1.2

1.4

—

(3022475) Manganese [Moles/volume] in Blood

10.01

2.98

1.0

0.21

0.15

umol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

501

0.51

2.97

1.2

1.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2182

22576

0.86

2.93

33.9

10.9

41.47

25.59

u/l

81.41

2148

21651

(3029937) Albumin [Presence] in Urine by Test strip

775

6960

1.16

2.93

5.2

4.1

0.00

estimate

0.69

270

2173

(3021601) Nitrite [Presence] in Urine by Test strip

1299

12087

1.14

2.91

4.8

4.0

0.00

estimate

0.50

324

2413

(3009261) Glucose [Presence] in Urine by Test strip

1322

12317

1.14

2.90

4.9

4.0

3.31

0.02

estimate

0.51

308

2273

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

500

4344

1.18

2.88

1.3

1.78

1.71

u/ml

0.05

101

1122

(3027974) Hepatitis B virus e Ag [Presence] in Serum

6.68

2.87

2.2

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

2.32

2.74

2.4

3.5

24.47

27.05

mu/l

0.09

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.93

2.61

1.2

74.17

97.56

1.20

(3022313) Gas panel - Capillary blood

161

1255

1.30

2.58

4.7

4.0

—

(40765096) Chromosome analysis panel by Banding

3.61

2.57

1.4

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

1243

0.72

2.55

1.2

1.3

268.59

250.56

u/ml

0.09

1159

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

165

1294

1.29

2.53

2.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

672

1.40

2.46

2.4

2.2

120.40

131.30

g/l

3.93

539

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.39

2.46

1.3

—

(4024509) Urine culture

1234

0.72

2.45

1.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.09

2.42

1.6

1.4

57.20

111.77

umol/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

174

1.79

2.42

1.3

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1664

17432

0.89

2.38

51.5

21.6

330.83

332.25

g/l

7.82

1652

17306

(3014765) Yersinia sp identified in Stool by Organism specific culture

575

1.42

2.38

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

243

1.66

2.37

1.5

1.3

—

(40768446) Kidney Pathology biopsy report

2.21

2.37

1.2

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.13

2.36

1.0

1.1

—

0.09

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

877

0.68

2.36

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

154

1.83

2.34

1.5

1.3

1.17

nmol/l

0.00

108

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

127

974

1.32

2.32

4.9

4.2

24.52

24.76

mmol/l

0.31

119

872

(3008536) Aspergillus sp Ab [Presence] in Serum

3.22

2.30

1.9

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

348

1.53

2.30

1.1

357.18

71.41

iu/ml

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

571

1.41

2.29

1.2

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

301

1.57

2.27

1.9

2.0

2.02

1.49

g/24h

0.52

157

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.46

2.27

2.8

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.48

2.27

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

178

1.75

2.26

2.2

1.6

7.93

8.18

mmol/l

0.16

178

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

254

3015

0.83

2.22

4.5

5.5

32.60

33.16

0.32

178

1940

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.86

2.20

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

2.86

2.20

1.2

1.5

33.85

58.42

u/l

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.41

2.19

2.8

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.41

2.19

2.8

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2197

22597

0.88

2.15

49.1

21.1

4.00

4.02

mmol/l

1.36

2158

22049

(42529406) Shigella sp [Presence] in Stool by Culture

579

1.39

2.14

1.2

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

619

5592

1.14

2.10

1.8

42773902.67

35129632.90

pmol/l

0.08

512

4566

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

264

0.45

2.09

1.3

1.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.91

2.07

1.8

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

146

1.79

2.06

2.5

2.0

61.00

280.07

ug/min

—

(3000330) Specific gravity of Urine by Test strip

168

1364

1.25

1.99

4.2

3.5

1.02

ratio

1.60

154

1251

(3014051) Protein [Presence] in Urine by Test strip

674

6140

1.13

1.99

3.4

3.1

0.00

0.04

1.31

211

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

312

2691

1.18

1.99

2.5

6.12

7.78

ug/l

0.91

274

2341

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

126

1.83

1.98

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

126

1.83

1.98

1.2

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2197

22565

0.89

1.97

49.0

21.0

137.92

139.77

mmol/l

130.49

2161

22063

(3040151) Glucose [Moles/volume] in Capillary blood

345

1.49

1.97

8.1

8.5

8.75

7.57

mmol/l

1.03

285

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.34

1.96

1.0

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

2.97

1.93

2.4

1.2

94.50

106.11

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

751

1.32

1.86

1.3

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.03

1.85

1.0

1.1

1656.62

1515.67

miu/ml

0.19

(3032057) Clostridioides difficile [Presence] in Stool

2.17

1.77

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

129

1600

0.80

1.76

1.6

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

3.34

1.74

1.2

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.50

1.74

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

103

1.85

1.71

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.30

1.70

1.2

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

975

9134

1.10

1.70

5.1

4.0

0.09

estimate

0.02

268

1955

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

308

1.47

1.68

1.8

1.5

—

(44813793) Dust mix specific IgE antibody measurement

130

0.38

1.62

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.58

1.61

1.0

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1007

9472

1.10

1.60

4.7

4.2

12.24

8.42

mg/mmol

1.75

686

6049

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

210

0.47

1.60

1.0

1.1

—

23.08

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

2.00

1.59

3.1

2.3

29.18

44.86

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.33

1.58

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

182

0.49

1.50

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.12

1.44

1.1

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.13

1.44

1.8

2.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.13

1.44

1.2

1.3

—

(44786800) Granulocytes/Leukocytes in Body fluid

2.73

1.43

1.0

1.3

42.83

21.86

—

(3052592) Norovirus Ag [Presence] in Stool

2.18

1.40

1.1

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

253

2220

1.15

1.36

1.2

1.4

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

155

1829

0.84

1.35

1.3

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.87

1.34

1.2

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

1.32

0.0

2.3

—

44.11

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

480

1.32

1.3

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

123

1018

1.22

1.31

3.3

3.1

4.15

4.43

pmol/l

2.64

107

880

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.50

1.30

1.0

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.00

1.27

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

269

1.42

1.25

1.3

1.4

29.77

29.01

iu/l

0.04

222

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

123

1.63

1.24

1.0

—

(4268621) Lupus anticoagulant assay

204

1.48

1.22

2.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

631

5878

1.09

1.22

4.1

3.9

0.00

0.14

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

774

0.77

1.21

1.4

1.6

—

(3017569) Oxygen content in Arterial blood

188

1.49

1.21

2.1

1.8

14.54

16.55

3.34

188

(3028717) Thiamine [Mass/volume] in Blood

2.31

1.18

1.0

1.2

49.17

64.85

ug/l

—

(3034426) Prothrombin time (PT)

1.93

1.17

1.5

1.3

29.36

28.63

0.22

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

211

0.57

1.16

1.4

1.2

—

96.63

—

(3004616) Nuclear Ab [Presence] in Serum

284

0.63

1.14

1.4

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

270

0.63

1.12

1.2

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

293

1.37

1.11

1.3

1.2

1.52

2.60

u/ml

0.82

102

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

696

0.77

1.10

1.3

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2187

21436

1.08

1.10

42.4

16.5

36.81

26.39

mg/l

37.13

2135

17704

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

137

0.51

1.09

1.0

1.1

—

0.43

—

(3020650) Glucose [Presence] in Urine

1.87

1.07

1.4

1.6

0.00

0.10

estimate

0.80

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

792

8359

0.93

1.05

2.2

2.3

174.16

233.24

u/l

2.52

749

7840

(4198724) Urine methamphetamine measurement

1.95

0.97

1.6

1.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

100

1.60

0.96

1.0

1.1

—

4.80

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

246

0.65

0.94

1.3

1.2

—

62.73

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.78

0.94

1.1

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

255

0.66

0.90

1.0

1.1

0.32

1.45

u/ml

—

141

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1755

17122

1.06

0.90

51.6

19.9

15.06

13.73

160.96

1742

16817

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.75

0.90

1.3

1.4

15.32

9.51

ug/l

0.94

(3000475) Leukocytes [#/volume] in Synovial fluid

706

0.80

0.88

1.6

1.5

15933.18

15024.34

e6/l

0.06

502

(3028433) Virus identified in Specimen by Culture

1.79

0.87

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.00

0.87

1.0

1.1

—

(4034850) Laboratory test

824

0.82

0.86

17.0

10.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

127

1457

0.87

0.86

1.2

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1060

10201

1.06

0.84

2.9

2.4

74.37

78.66

nmol/l

4.65

979

8950

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

479

0.77

0.83

1.5

1.8

2.30

16.19

iu/l

—

185

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.74

0.82

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

223

1.35

0.81

1.2

322.09

346.46

nmol/l

0.25

179

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.61

0.81

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

582

1.21

0.80

1.5

1.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

891

0.84

0.79

1.4

1.7

5.17

6.12

iu/ml

0.21

208

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.79

0.0

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.78

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.78

0.0

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

602

1.20

0.78

1.6

0.24

0.23

g/l

0.28

571

(36660697) Celiac disease serology panel - Serum

174

1558

1.12

0.77

1.2

—

(3004451) EKG impression Narrative

165

1.40

0.77

1.1

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

494

0.79

0.76

1.3

1.4

84.62

977.77

e6/l

1.72

402

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

290

3142

0.91

0.75

13.8

7.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

253

1.31

0.75

1.3

1.4

—

nmol/l

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.92

0.70

1.4

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

488

0.80

0.70

1.3

1.93

33.74

e6/l

1.52

375

(40757373) Influenza virus identified in Isolate

1.53

0.68

1.0

1.4

—

(3028300) Cannabinoids [Presence] in Urine

273

0.73

0.68

1.8

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

975

9415

1.05

0.67

3.9

3.5

7.03

7.48

mmol/l

2.86

811

7869

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

156

0.64

0.67

1.4

1.1

—

(3027008) Opiates [Presence] in Urine

272

0.73

0.67

1.8

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

0.53

0.66

1.0

1.2

—

39.99

—

(3008898) HLA-B27 [Presence]

493

0.81

0.64

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

269

0.74

0.63

1.8

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

269

0.74

0.63

1.8

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

325

0.77

0.62

1.5

—

(3045424) Erythrocytes [Presence] in Urine

126

1125

1.13

0.62

2.4

2.0

0.00

0.76

estimate

0.50

331

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.6

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.59

0.0

1.0

—

74.96

—

(3003129) Base excess in Capillary blood by calculation

333

0.78

0.59

2.7

2.2

-0.37

0.23

mmol/l

0.22

319

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.58

0.0

1.3

—

330.12

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

116

0.60

0.57

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

230

0.74

0.57

1.4

18.56

25.79

—

153

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

220

1.28

0.57

1.8

2.1

1.41

1.45

u/field

0.03

121

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

292

1.24

0.56

1.2

1.4

1.11

6.68

nmol/l

0.45

283

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.58

0.56

2.8

1.4

14.56

7.60

ug/l

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.62

0.55

8.7

13.1

4.72

5.09

mmol/l

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

206

0.73

0.55

1.0

1.1

3.66

4.52

u/ml

—

103

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

284

1.24

0.55

1.3

1.2

2.27

6.87

u/ml

2.18

137

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

697

0.86

0.54

1.7

1.9

56.61

43.60

nmol/l

2.90

669

(3008401) Mugwort IgE Ab [Units/volume] in Serum

205

0.73

0.54

1.0

1.1

0.03

1.48

u/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

696

0.86

0.53

1.3

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1035

10637

0.96

0.52

2.8

2.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

1.40

0.51

1.1

—

(3014271) Vancomycin [Susceptibility]

162

1.30

0.50

2.6

3.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.49

2.2

2.4

4.55

4.99

kpa

0.78

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.49

2.2

2.4

10.22

9.77

kpa

0.26

(3023511) Choriogonadotropin [Units/volume] in Urine

1.56

0.49

1.0

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

1.37

0.48

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

111

0.63

0.48

2.1

1.8

—

(4146454) Self-monitoring of blood glucose

336

1.19

0.47

2.7

2.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

429

0.84

0.46

1.2

—

55.05

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.61

0.45

1.0

1.1

—

23.32

—

(3018333) Ribosomal P Ab [Presence] in Serum

156

1.28

0.45

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

165

1.27

0.45

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

253

0.79

0.44

1.8

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1.37

0.43

1.2

1.4

0.10

0.21

nmol/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1193

11680

1.04

0.42

2.3

90.15

93.60

pmol/l

1.74

650

6255

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1047

0.90

0.42

1.1

1.2

149.78

115.12

u/ml

0.20

373

(44806420) Estimation of glomerular filtration rate

185

1.25

0.41

3.6

2.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

150

0.73

0.41

1.5

143.01

164.20

pmol/l

0.29

150

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

261

0.80

0.41

1.2

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(3044941) Cell count panel - Synovial fluid

487

0.86

0.40

1.3

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

304

0.82

0.40

1.3

1.5

46.47

64.29

1.02

197

(3025018) Bordetella pertussis Ab [Titer] in Serum

101

0.69

0.39

1.4

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

214

1.22

0.39

1.2

96.04

95.98

0.00

201

(3010726) Horse dander IgE Ab [Units/volume] in Serum

182

0.77

0.39

1.0

1.1

3.46

1.67

u/ml

—

(3019174) dRVVT (LA screen)

0.00

0.39

0.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

160

1.25

0.38

1.1

—

(3014891) Appearance of Pleural fluid

1.39

0.38

2.4

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

269

0.82

0.38

1.4

1.2

16449.21

167755.56

e6/l

2.73

181

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

170

1.24

0.37

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

170

1.24

0.37

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.27

0.36

9.8

7.0

5.90

5.28

kpa

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

181

1.22

0.34

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

172

1.22

0.34

1.0

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

308

0.84

0.34

1.1

—

4.11

—

(3033099) Centromere Ab [Titer] in Serum

1.33

0.33

1.0

1.2

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1684

16631

1.03

0.33

5.3

4.5

22.08

13.02

mm/h

52.45

1551

15417

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

136

1.25

0.33

2.2

1.9

14.85

16.88

nmol/l

0.44

121

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

136

1.25

0.33

1.6

1.9

475.44

273.74

mu/l

—

102

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

109

1.29

0.33

1.6

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

256

1.17

0.33

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.28

0.32

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.73

0.30

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.71

0.30

26.6

14.8

1907.14

1407.25

nmol/l

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

249

1.17

0.30

1.0

1.3

—

71.40

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

268

1.16

0.30

1.2

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.23

0.29

3.0

2.1

0.50

1.19

ug/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

109

0.73

0.29

1.6

2.4

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

109

0.73

0.29

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

110

0.73

0.28

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

173

0.81

0.28

2.9

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.25

0.27

1.3

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

196

1.17

0.27

1.1

—

(3019150) Specific gravity of Urine by Refractometry

559

5732

0.97

0.27

5.3

4.2

1.02

1.29

kg/l

0.50

399

3776

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

548

1.10

0.26

2.1

2.0

14.09

12.22

mg/l

0.73

503

(3012516) Albumin [Mass/volume] in Urine

943

9268

1.03

0.26

3.9

3.5

62.89

48.55

mg/l

1.29

666

6100

(21491868) Cryoglobulin [Mass/volume] in Serum

1.30

0.26

1.1

1.2

—

0.06

g/l

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

436

0.89

0.26

1.1

1.4

—

9.66

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

482

1.10

0.25

1.2

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

170

0.82

0.25

1.2

1.3

103.50

99.86

pmol/l

0.09

170

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.71

0.24

1.3

2.2

10.48

106.85

ug/l

—

(3044927) Protein electrophoresis panel - Urine

327

0.89

0.23

1.3

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.22

0.22

1.4

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.5

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.2

—

7.87

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

4.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

10.02

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

2.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.16

0.21

1.2

1.3

—

61.33

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.16

0.21

1.0

—

0.32

u/ml

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.24

0.21

1.1

1.2

—

(40768443) Skin Pathology biopsy report

897

1.06

0.20

1.1

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.20

0.0

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

155

0.84

0.20

1.8

81.30

121.02

ng/l

1.48

155

(3006462) Nitrate [Presence] in Urine

108

1.20

0.20

2.7

3.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.22

0.20

1.0

1.1

—

(3022621) pH of Urine by Test strip

182

1891

0.96

0.20

3.3

2.8

5.97

6.06

0.83

147

1349

(3036071) Salmonella sp Ab [Titer] in Serum

1.13

0.18

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

177

1835

0.96

0.18

2.1

2.3

12.71

15.18

nmol/l

2.72

151

1643

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1.13

0.17

2.0

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

204

0.88

0.16

1.8

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.20

0.16

1.3

143.18

177.68

mmol/24h

1.30

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

235

1.11

0.15

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.78

0.15

1.8

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

264

1.10

0.15

1.2

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.75

0.15

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

150

0.87

0.14

3.1

2.4

—

(3024263) Appearance of Synovial fluid

139

0.86

0.14

1.1

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

744

1.05

0.13

1.6

31.70

24.23

u/ml

0.28

133

(3027456) Digoxin [Moles/volume] in Serum or Plasma

734

0.95

0.13

2.8

3.3

0.80

0.84

nmol/l

0.50

589

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

639

1.05

0.12

1.4

1.5

1.25

5.49

iu/ml

0.42

131

(3023419) Bacteria identified in Sputum by Culture

366

1.07

0.11

1.7

2.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

546

0.95

0.10

3.7

3.8

34.67

29.75

mg/l

0.51

397

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.11

0.09

1.2

1.1

—

(4133840) Spirometry

1.11

0.09

2.4

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

747

0.96

0.09

1.3

1.4

—

(3000492) Spirometry study

189

1928

0.98

0.09

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

204

1.08

0.08

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.05

0.08

8.0

7.0

10.18

10.42

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.03

0.08

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.81

0.08

1.0

1.2

18.80

9.76

mm/h

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.04

0.08

1.3

—

(4015189) Microbial culture of sputum

0.81

0.07

1.7

2.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.07

0.07

1.0

1.1

—

(3017704) Immunofixation for Urine

147

1.09

0.07

1.0

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

224

0.94

0.06

1.1

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

183

0.93

0.06

1.1

—

(4195642) Thrombophilia screening test

256

1.06

0.06

1.3

1.2

—

(4211845) Urine protein measurement

119

1.09

0.06

2.7

3.5

—

(3000034) Microalbumin [Mass/volume] in Urine

237

1.06

0.05

4.2

2.9

38.95

29.51

mg/l

0.16

179

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

100

1.10

0.05

1.2

39.76

38.45

g/l

0.28

100

(3028707) Methadone [Presence] in Urine by Screen method

120

1.08

0.04

1.7

1.4

—

(3045414) Leukocytes [Presence] in Urine

231

2331

0.99

0.04

2.4

2.0

0.02

0.01

estimate

0.29

449

(3023410) Appearance of Cerebral spinal fluid

200

1.05

0.03

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

776

7741

1.00

0.02

1.9

1.7

18.13

19.76

nmol/l

2.83

713

6486

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

207

0.97

0.01

1.0

1.1

—

3.02

—

(3005570) Glucose [Moles/volume] in Urine

253

1.03

0.01

1.5

2.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

136

0.96

0.00

4.3

4.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

216

0.97

0.00

1.1

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

204

1.03

0.00

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

224

1.03

0.00

1.0

1.4

—

272.14

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

286

0.98

0.00

3.6

3.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

215

1.02

0.00

1.0

1.4

—

65.56

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

155

1.03

0.00

2.1

1.9

72.94

96.26

umol/l

2.63

155

(3047007) Chlamydophila sp Ab [Presence] in Serum

224

0.98

0.00

1.1

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

130

1.00

0.00

1.1

1.2

109.15

141.21

nmol/l

1.85

130

(3047189) Immunofixation for 24 hour Urine

101

0.99

0.00

1.5

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

105

0.95

0.00

1.0

1.6

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.92

0.00

2.3

1.7

44.67

68.66

nmol/24h

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.1

—

1.32

—

(3022689) Creatine [Moles/volume] in Urine

0.94

0.00

1.3

1.4

7.08

7.75

mmol/l

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

0.97

-0.00

1.0

1.1

—

30.67

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

257.00

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

-0.00

0.0

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

1.02

-0.00

8.8

6.0

9.10

8.43

mmol/l

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

-0.00

0.0

2.4

—

633.00

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

400.83

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.90

-0.00

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.04

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.35

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.00

-0.00

1.0

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

166.83

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

0.01

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

4.57

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

0.95

-0.00

1.0

1.2

—

12.09

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_BILIARY_GALLBLADDER_WIDE – Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

GWS hits: 4

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo (C3_BILIARY_GALLBLADDER_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints